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ABSTRACT
Glucocorticoids are required for the development o f all forms of experimental
obesity.

Studies on Zucker fa/fa rats have revealed that the obese Zucker rat is

hyper-responsive to the effects o f glucocorticoids. This excessive response may result
from an alteration in level or activity o f a transcription factor in nuclei o f obese fa/fa
rat. Evidence from gel retardation assays using DNA fragments from the upstream
region o f glucocorticoid regulated tyrosine aminotransferase (TAT) gene and the
nuclear extracts from obese and lean rats showed in this study that an increased
amount o f DNA fragment was shifted by nuclear extracts from obese rats in
comparison to that from lean rats, suggesting that an alteration in levels or activity o f a
transcription factor or factors was present in the nuclei of obese rats. Three proteins
which have approximate molecular weight o f 55, 59 and 62 K.Da were purified from
the specific DNA-protein complex which showed a difference between lean and obese
rats.

These three proteins were able to reconstitute the specific DNA-protein

complexes in gel retardation assays. Antibody against glucocorticoid receptor did not
alter the gel retardation pattern, while anti-HNF3a (hepatic nuclear factor 3a)
antibody caused a super-shift o f DNA-protein complex, suggesting that HNF3a was
one o f the three proteins which formed the DNA-protein complexes. Northern blot
analysis showed no significant difference in mRNA levels o f HNF3a gene between
lean and obese rats, suggesting that the increased formation of DNA-protein complex
in obese rat may not reflect an increased amount of protein but may results from an

x

increased affinity o f HNF3a or an increased level or affinity of the other two nuclear
proteins in the nuclei o f obese rats. Dephosphorylation of the nuclear proteins altered
the gel retardation pattern, suggesting that phosphorylation regulated the specific
DNA-protein complex formation. Although the glucocorticoid receptor was not a part
o f the DNA-protein complex, the formation of the specific DNA-protein complexes
changes in response to the change o f glucocorticoid status, suggesting that the
transcription factors that are responsible for the specific DNA-protein complex
formation may be modulated directly or indirectly by glucocorticoids.

INTRODUCTION
Obesity is a major nutritional disorder in western societies. In America, more
than three in ten of adults weigh at least 20% in excess of their ideal body weight
(Watson, 1995). Increased body weight is not only a cosmetic but also an important
public health problem since it is associated with type II diabetes, hypertension,
hyperlipidemia, gallbladder disease, risks of heart disease, excess mortality and certain
cancers (Zhang, et al., 1994, Bray, 1995).
Obesity refers to an excess of body fat. In most cases it develops in the absence
of any underlying disease process (Foster, 1993). Greater energy intake than expenditure
is generally accepted as a direct cause o f obesity. However, the molecular mechanism
underlying the energy imbalance is not understood.
Research on human subjects is of limited scope in terms o f understanding the
molecular mechanisms o f the development o f obesity. Experimental animal models o f
obesity are available for this purpose. Four major types of animal obesities have been
described in the literature.

They are dietary obesity, hypothalamic obesity, genetic

obesity and endocrine obesity (Bray and York, 1979, Bray et al., 1990). It has been
proposed that all these experimental obesities result from a defect in nutrient-regulated
activity of the autonomic nervous system and their development are all dependent on
glucocorticoids (Bray et al., 1990).
The Zucker fatty rat is one of the animal models of genetic obesity. It shares
many similarities with obesity seen in humans (Krief and Bazin, 1991). The obesity of
the Zucker rats has been shown to result primarily horn an imbalance in the autonomic
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responses to feeding which leads to impaired sympathetically mediated thermogenesis
and enhanced parasympathetically mediated insulin secretion and fat deposition which is
further exaggerated by a hyperphagia (Bray et al., 1989, 1990, Marchington et al., 1983,
Jeanrenaud, 1985, York et al., 1985).
The Zucker fatty rat inherits obesity as an autosomal recessive trait due to a
single gene {fa) mutation which has been mapped to rat chromosome 5 (Truett et al..
1991). The expression of the genetic defect in obese Zucker rats begins very early in life
(Lavau et al., 1985) although the obese rats can be visually distinguished from their lean
littermates at 4-5 weeks o f age as the total body fat reaches about 20% o f the body
weight (Bell and Stem, 1977). Deposition o f excess fat in homozygous fa/fa rats begins
at birth or shortly thereafter (Lavau et al., 1985). A positive energy balance is a direct
cause for the excess fat deposition.

Sympathetically-mediated diet-induced brown

adipose tissue (BAT) thermogenesis is reduced in Zucker fatty rats and the reduced BAT
thermogenic capacity, as measured in terms of GDP binding to isolated BAT
mitochondrial membrane, can be observed at 2 days of age (Bazin et al., 1984). The
parasympathetically mediated basal level of insulin secretion is increased and the
stimulated level of insulin secretion is also increased in Zucker fatty rats
(Rohner-Jeanrenaud et al., 1983, 1985, Krief and Bazin, 1991, Stubbs and York, 1991),
resulting in a gradual development of insulin resistance (Crettaz et al., 1980, Czech et al..
1978, Kemmer et al., 1979, Terretaz et al., 1986). Hyperphagia starts at 3 weeks of age
in Zucker fatty rats (Bray and York, 1979, Bray, 1977, Dilletuso and Wangsness, 1977).
Although excessive food intake contributes greatly to the oveideposition of fat in obese
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fa/fa rats, the hyperphagia is not an essential requirement for the development o f the
obesity in Zucker fatty rats (Dilettuso and Wangsness, 1977).
The dependence on glucocorticoids for the development of obesity in Zucker
fatty rats was supported by the evidence that adrenalectomy prevents the further
development of obesity (Bray et al., 1979, 1989, 1990, York, 1989, lonescu et al., 1988),
and abolishes most o f the abnormalities associated with this obese syndrome (Bray et al.,
1990, Holt and York, 1982. York, 1989, Freedman et al., 1985).

Treatment o f

adrenalectomized fa/fa rats with glucocorticoid replacement restores the obesity as well
as the abnormalities associated with this syndrome. (Planche et al., 1983, York, 1989,
Freedman et al., 1985). In contrast to that of obese rats, the adrenalectomy of lean rats
only caused small changes in food intake, energy balance, sympathetic activity and
insulin secretion.

Replacement treatment of adrenalectomized lean rats with

glucocorticoid hormone did not lead to the development o f obesity (Bray, 1979, Bray et
al., 1990, Shargill et al., 1983, Guillaume-Genti! et al., 1990). Moreover, treatment of
young Zucker fatty rats with the glucocorticoid receptor (GR) antagonist RU486 not
only prevents but also reverses the obesity, while RU486 has little effect on lean Zucker
rats (Langley and York, 1990).
aminotransferase

(TAT),

malic

Furthermore, the mRNA levels o f tyrosine
enzyme

(ME)

and

glyceraldehyde-3-phosphate

dehydrogenase (GAPDH) genes were markedly reduced in Zucker fatty rats by
adrenalectomy and showed a dose and time dependent increase after corticosterone
replacement, whereas glucocorticoid status had much smaller effects on the mRNA
levels o f TAT, ME and GAPDH genes in lean rats (Bray et al., 1991, Jenson et al..
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1995). li has also been demonstrated that circulating levels o f corticosterone and diurnal
variation in corticosterone appear to be normal in young fatty rats (Shargill, et al., 1983).
With increase o f age, there is a small increase in corticosterone levels and a gradual loss
o f the diurnal rhythm in obese rats (Martin, 1978). This minor change in corticosterone
levels cannot account for the glucocorticoid dependence. These observations indicate
that the obese Zucker rat is, in fact, hyper-responsive to the effects of corticosterone
(York, 1989, Freedman et al., 1985).
Glucocorticoid activities are mediated through glucocorticoid receptors which act
as transcription factors and regulate gene expression at the level of transcription. (Tsai
and O'Malley, 1994). The excessive response to glucocorticoids in obese fa/fa rats,
especially the evidence of elevated mRNA levels of TAT, ME and GAPDH, and their
exaggerated responses to manipulation of adrenal status of the obest fa/fa rats suggested
that the defect in glucocorticoid control processes may result from an alteration in levels
or activity of a transcription factor in nuclei of obese fa/fa rat.
The purpose of the present study was to investigate the molecular mechanism o f
the altered glucocorticoid responsiveness in obese fa/fa rat. The major findings o f this
study were that: (1) A difference in binding of nuclear proteins from lean and obese rats
to the upstream region of TAT gene which is positively regulated by glucocorticoids was
observed using get retardation assay. A larger amount of DNA fragment was shifted
with nuclear proteins from obese rats than that from lean rats in several regions o f
upstream of TAT gene. (2) The formation of the DNA-protein complex changed in
response to the change of the glucocorticoid status in lean and obese rats.

(3) Phosphorylation of nuclear proteins was involved in the formation o f specific
DNA-protein complexes.

(4) Three proteins were isolated from the DNA-protein

complex and these three proteins were capable o f reforming the DNA-protein complex
in gel retardation assays.

(5) Antibody interference in gel retardation assays

demonstrated that the glucocorticoid receptor was not necessary for the formation o f the
specific DNA-protein complexes which exhibit the difference between lean and obese
rats, while HNF3a was present in the DNA-protein complex.

(6) No significant

difference in the mRNA levels of HNF3 gene was detected between obese and lean rats,
suggesting that there may be no difference in amount o f proteins and the difference in
amount o f complex formation between lean and obese rats may result from an alteration
of the affinity of the protein to the DNA or from a defective transcription factor other
than HNF3a.

REVIEW OF LITERATURE

Obesity
Obesity, based on etiology, can be classified as genetic, dietary, hypothalamic,
endocrine, physical inactivity, viral infection and drug-induced obesity (Bray, 1995,
York, 1993). In most cases, obesity develops in the absence of any underlying disease
process. Greater energy intake than expenditure is the direct cause o f obesity but the
underlying cause of the energy imbalance is not understood (Foster, 1992).
Experimental animal models o f obesity have been used widely for understanding
the development o f obesity. Four major groups o f animal obesities have been described.
They are dietary obesity, hypothalamic obesity, genetic obesity and endocrine obesity
(Bray and York, 1979, Bray etal., 1990).
The animal models of genetic obesity inherit obesity either through a single gene
defect or as a consequence of multiple gene defects (York, 1992). The single gene
inherited obesities may reflect either a defect in expression of a dominant gene or the
presence o f a recessive gene. The most extensively studied genetic obesities are those
inherited as single recessive genes, such as the diabetic mouse (tih/dh), obese mouse
(ob/ob), and fatty rat ifa/fa). The oh gene has recently been cloned (Zhang et al., 1994).
The normal product of ob gene is a protein that is secreted by fat cells. It may function
as part o f a signaling pathway from adipose tissue that acts to regulate the size of the
body fat depot. Data from parabiosis experiments suggest that the db gene may encode a
receptor for ob gene product since the db/db phenotype appears to reflect a defect in the
action o f ob protein (Zhang et al., 1994, Rink, 1994).
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These two mutants are
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phenotypically identical when they are in the same genetic background. The fa gene is
syntenic with db gene (Truett et al., 1991). Research on fa mutants, the Zucker fatty rats,
to discover the molecular pathogenesis of this genetic obese syndrome is a task of
significance since this animal model shares many similarities with obesity seen in
humans (Krief and Bazin, 1991),

Zucker Fatty Rats
1.

The Genotype o f Zucker Rat
The Zucker fatty rat was first described by Zucker and Zucker in 1961.

It

resulted from a spontaneous mutation in a cross between the Merck Stock M and
Sherman rats (Zucker and Zucker, 1961, Bray, 1977). The obesity is transmitted as an
autosomal recessive trait due to a single gene {fa) mutation which has been mapped to rat
chromosome 5 (Truett et al., 1991). The homozygous recessive animal {fa/fa) becomes
phenotypically obese and the heterozygote (Faifd) remains lean.

The homozygous

(Fa/Fa) and the heterozygous (Fatfa) lean rats are phenotypically indistinguishable
although some moderate effects of the single gene, such as gene-dosage dependent
changes in serum free fatty acid and triglycerides, brown adipose tissue and
mitochondrial GDP binding activity, have been reported (York et al., 1984). Truett et al.
(1995) argued that the effects o f fa gene on early development o f obesity are codominant
rather than recessive. They demonstrated that fa copy number had linear effects on body
and inguinal adipose tissue at 7 days of age. At 14 days of age, the fa copy number had
linear effects on body, inguinal adipose pads as well as interscapular brown adipose
tissue weights.
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2.

The Development o f Obesity in Zucker Rats
The phenotypic abnormalities of the Zucker obese rats include hyperadiposity,

hyperphagia. hyperinsulinemia, insulin resistance and reduced brown adipose tissue
thermogenesis (Bray and York, 1979, York, 1992). Although the obese (fa/fa) rats can
be visually distinguished from their lean littermates at 4-5 weeks of age as the total body
fat reaches about 20% of the body weight (Bell and Stem, 1977), the phenotypic
emergence of this genetic defect begins very early in life (Bazin et al., 1984, Truett et al..
1995).
(1)

Hyperadiposity
Deposition of excess fat in homozygous fa/fa rats begins at birth or shortly

thereafter (Lavau et al., 1985).

The initiation o f hyperadiposity is independent of

hyperphagia and hyperinsulinemia although it can be amplified by these two factors
(Krief and Bazin, 1991, Dugail et al., 1992).
The excess fat deposition results from both increased lipogenesis and decreased
lipolysis. The increase in lipogenesis is due to an increase in expression of a group o f
genes encoding for fatty acid synthetase and other lipogenic enzymes at a transcription
level (Dugail et al., 1988, 1989).

The activities of several enzymes involved in

lipogenesis such as fatty acid synthetase, citrate cleavage enzyme, malic enzyme,
glucose-6-phosphatc dehydrogenase, and 6-phosphogluconate dehydrogenase and
lipoprotein metabolism such as lipoprotein lipase as welt as glycolysis such as
glyceraldehyde-3-phosphate dehydrogenase are enhanced in white adipose tissue from
preobese pups (Krief and Bazin, 1991).

Dugail et al. (1992) demonstrated that the
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mRNA levels o f a number of lipid storage-related enzymes, such as lipoprotein lipase
(LPL), GAPDH and ME, were higher in adipose tissue from obese rats than that from
lean rats in the suckling period, and the increased mRNA level is in close correlation
with genotype-mediated differences in enzyme activities, suggesting that the increased
lipid storage capacities of white adipose tissue may be regulated at the transcriptional
level.
In addition to the increase in lipogenesis, a decrease in lipolysis is also present in
the young obese rats. Adipocytes from fatty rat showed an increased sensitivity of the
membrane component that inhibits lipolysis, thus tending to enhance fat cell
accumulation of lipid (Bray et al., 1990).
The increased fat deposition is accommodated by an increase in the size and the
number o f adipocytes in fat depots (Bray and York, 1979). The fat cell size increased as
early as 5 days of age (Boulange et al., 1979, Planche et al., 1983, 1988) and the early
overdevelopment of the adipose tissue extends into maturity. In the obese rat, adipocytes
undergo enlargement and proliferation for as long as 26 weeks whereas in lean rats the
process continues for the first 14 weeks o f life (Johnson et al., 1971).
(2).

Positive energy balance
Positive energy balance, which results from an increase in energy intake and a

decrease in energy expenditure, is necessary for the excess fat deposition. In the Zucker
fatty rat, the hyperphagia starts at 3 weeks of age (Bray and York, 1979, Bray, 1977.
Dilletuso and Wangsness, 1977). However, defective thermogenesis and hyperadiposity
develop in the first week o f life (Planche et al., 1983). Moreover, food restriction docs
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not prevent the development o f complete obese syndrome in Zucker fatty rats (Johnson
et al., 1973, Cleary et al., 1980, Bray et al., 1973, Pullar and Webster, 1974). Zucker
fatty pups, which are pair-fed to prevent the emergence o f hyperphagia, still deposit
more fat than their lean counterparts. This research evidence indicates that an increased
energy efficiency (e.g. a decreased energy expenditure) is present in these animals
(Thenen et al., 1984) and that the hyperphagia in obese fa/fa rats is not an essential
requirement for the development of the obesity although an excessive food intake
contributes greatly to the overdeposition of fat in obese fa/fa rats (Dilettuso and
Wangsness, 1977).
Developmental studies in preobese Zucker rats suggest that increased lipid
storage leading to obesity in Zucker rats is a consequence of a defect in energy
expenditure (Krief and Bazin, 1991).

A large number of experimental observations

demonstrated that a defect of sympathetically mediated thermogenesis (e.g. a reduced
energy expenditure) is present in Zucker fatty rats. One of the earliest defects o f the
Zucker obese pups is a reduced oxygen consumption which has been detected as early as
2 days of age (Moore et al., 1985, Planche et al., 1983, 1986).

A reduced core

temperature in obese rats has been shown to be detectable from day 6 onwards (Planche
et al., 1983).

The sympathetically mediated and diet-induced brown adipose tissue

(BAT) thermogenesis is diminished in fatty rats (Planche et al., 1986).

BAT'

thermogenic capacity, as measured in terms of GDP binding to isolated BAT
mitochondrial membrane, is reduced by 50% at 22-24°C in fatty rats compared with their
lean littermates (Holt and York, 1982) and this defect can be observed at 2 days o f age

II
(Bazin et al., 1984).

A reduced mRNA level of the gene encoding the uncoupling

protein which is responsible for GDP binding to BAT mitochondrial membrane has also
been detected in 10 day old rats (Ricqier et al., 1986). In addition, atropine restores the
oxygen consumption of obese rats to normal level after feeding (Rothwell et al., 1982),
suggesting that the increased parasympathetic tone of these animals may contribute to
their reduced thermic response to feeding.
It is apparent that the increased energy efficiency results in excess energy storage
as fat in obese rats. The imbalance in autonomic system is possibly an underlying cause
o f this positive energy balance.
(3).

Hyperinsulinemia and insulin resistance
Hypersecretion of insulin is a common feature in Zucker fatty rats. Although

basal insulin level does not differ between phenotypes until weaning, the insulin as well
as the glucagon response to a glucose or an arginine load is greater in 17-day-old
preobese pups than in lean pups, indicating an early onset of a glucose intolerance
(Rohner-Jeanrenaud et al., 1983, 1985, Krief and Bazin, 1991). This defect is mediated
by the parasympathetic nervous system and is attenuated by vagotomy or pre-treatment
with atropine. Therefore, it is suggested that an increased parasympathetic stimulation to
the endocrine pancreas is present in Zucker fatty rats (Rohner-Jeanrenaud et al., 1983,
1985, Krief and Bazin, 1991).
The development of hyperinsulinemia is associated with a gradual development
o f insulin resistance.

The Zucker fatty rat develops hepatic and peripheral insulin

resistance after weaning (Crettaz et al., 1980, Czech et al., 1978, Kemmer et al., 1979,
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Terretaz et al., 1986). The insulin resistance develops in muscle sooner than it does in
white adipose tissue which may potentiate anomalies by preferentially channelling
glucose toward adipose tissue rather than toward the skeletal muscular mass (Penicaud et
al., 1986).
Milbum et al. (1995) have demonstrated that an increase in adipose tissue in
obese rats results in an increase in basal insulin secretion. They provided the evidence
that the increased levels of free fatty acid (FFA) not only induced insulin secretion but
also enhanced D-cell replication, and thus caused or contributed to the increase in the
B-cell volume fraction of obese rats. The FFA elevation was also capable of inducing an
increase in low Km glucose usage (Milbum et al., 1995).

Since insulin secretion is

coupled to glucose metabolism (Meglasson and Matchinsky, 1986), the FFA-induced
increase in low Km glucose metabolism could be the cause of the hyperinsulinemia at
substimulatory glucose concentrations (Milbum et al., 1995).

The inability of

hyperinsulinemia of obesity to reduce FFA levels to normal implies a resistance of
adipocytes to the antilipolytic action of insulin (Campbell et al., 1994).

Glucocorticoids
Glucocorticoids are a class of steroid hormones synthesized from cholesterol in
the adrenal cortex (Baxter and Rousseau, 1979).

Naturally occurring steroids with

glucocorticoid activity include cortisol mainly in human and corticosterone mainly in
rodents.

A variety of synthetic glucocorticoids have been developed, such as

dexamethasone, which is more potent than the natural glucocorticoids by virtue o f a
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longer half-life in plasma, and greater affinity for glucocorticoid receptors (Baxter and
Rousseau, 1979).
Since glucocorticoids are members of steroid hormones, they are highly lipid
soluble but poorly water soluble. After they are synthesized, they can simply diffuse
across the plasma membrane of the steroid-producing cell and enter the circulating blood
system. In plasma, the hormones combines with globulin, and to a lesser extent, with
albumin. About 94 per cent of the hormone is normally transported in the bound form
and only 6 per cent exists in the free form in plasma (Vander et al., 1990). The free
hormone is in equilibrium with the bound hormone and only the free hormone can cross
capillary walls and encounter its target cell. Once the glucocorticoids enter the target
cell, they combine with glucocorticoid receptors. The receptors are thus activated and
capable of translocating into the nucleus where they are able to interact with
glucocorticoid responsive element (GRE) of DNA to stimulate the gene expression (Tsai
and O'Malley, 1994).
Glucocorticoids are degraded mainly in the liver where they are conjugated
primarily to form glucuronides and, to a lesser extent, sulfates. About 25 per cent of this
is excreted in the bile present in the feces, and the remaining 75 per cent in the urine.
The conjugated forms of these hormones are inactive (Vander et al., 1990).
Synthesis of glucocorticoids is regulated by a feedback loop system involving the
hypothalamus, anterior pituitary and adrenal cortex. Corticotrophin releasing hormone
(CRH), synthesized in the paraventricular nucleus (PVN) of the hypothalamus, promotes
the synthesis and release of adrenocorticotropin hormone (ACTH) by the pituitary.
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ACTH in turn stimulates corticosterone synthesis in the adrenal cortex (Munck and
Naray-Fejes-Toth, 1995). Glucocorticoids inhibit the synthesis and release of ACTH
directly by suppressing proopiomelanocortin (POMC) expression in the anterior pituitary
and indirectly by inhibiting the synthesis and secretion o f CRH in the PVN, and hence
curtail their own synthesis.

The occurrence o f the feedback inhibition of ACTH

secretion can be fast (within 30 minutes of hormone administration), delayed (within
minutes to hours) or slow (within hours to days) (Keller-Wood and Dallman, 1984,
Dayanithi and Antoni, 1989). The feedback regulation of glucocorticoids is mediated by
both glucocorticoid (type I) receptor and mineralocorticoid (type II) receptor (Bradbury
et al., 1991), and requires both RNA and protein synthesis (Dayanithi and Antoni, 1989).
Glucocorticoids have functions in regulation of metabolism, anti-inflammation,
immunosuppression and protection against stress. They have actions on both peripheral
tissue and the central nervous system (CNS).

The effects of glucocorticoids on

metabolism in peripheral tissue could be summarized as being anabolic in the liver but
catabolic in nonhepatic tissues (York, 1993).

The best-known metabolic effect of

glucocorticoids in peripheral tissues is their ability to stimulate hepatic gluconeogenesis.
This results mainly from two different effects o f glucocorticoids.

First, the

glucocorticoids activate the gluconeogenic pathway by increasing expression o f the
genes encoding gluconeogenic enzymes in the liver (Baxter and Rousseau, 1979).
Second, they enhance muscle protein breakdown and adipose tissue lipolysis to mobilize
substrates for gluconeogenesis (Vander et al., 1990). On the other hand, the hormones
decrease glucose utilization by the cells of all the tissues of the body except brain. As a
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result, blood glucose concentration is elevated and glycogen storage in the liver is
markedly increased.

In contrast to muscle protein breakdown and adipose tissue

lipolysis, hepatic protein synthesis and lipogenesis increase. (York, 1993).
In the CNS glucocorticoids have important actions in regulating metabolism,
feeding behavior, autonomic activity and stress responses (Bohus et al.. 1982, Funder et
al., 1987, Micco et al.. 1980). These actions may be modulated through interactions
with both type I and type II glucocorticoid receptors (Funder et al., 1987). It has been
suggested that the central glucocorticoid actions in controlling body energy stores may
be modulated either directly or indirectly through their ability to regulate the production
or secretion o f other peptides or hormones (York, 1993).

Examples of this are the

regulation

hormone

of

hypothalamic

corticotropin

releasing

(CRH)

and

proopiomelanocortin (POMC) family of peptide hormones by glucocorticoids (Sapolsky
et al., 1986, Drouin et al., 1987, York, 1993).
negatively regulated by glucocorticoids.

These hormones are known to be

CRH is a potent stimulator of sympathetic

activity and is capable of inhibiting food intake. Therefore, CRH and glucocorticoids
have opposite effects on energy balance through their actions on food intake and
autonomic response to feeding. They influence the relative partitioning o f energy among
fat, protein and carbohydrate in body stores, and balance energy storage and expenditure
in the form o f heat (York, 1992).

POMC is a precursor of several pituitary and

hypothalamic peptide hormones, such as ACTH. endorphins, melanocyte-stimulating
hormone. Endorphin peptide has been suggested to be associated with overeating in
genetically obese mice (ob/oh) and rats (fa/fa) (Margules et al., 1978). It has also been
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suggested that endorphinergic pathway may be involved in the CRH stimulation of
sympathetic activity and metabolic rate (Hardwick et al.. 1989). Thus it is apparent that
the peptide hormones of the POMC family have functions opposite to the
glucocorticoids in body energy balance.

Glucocorticoid Receptor
Effects of glucocorticoids on responsive cells are mediated by glucocorticoid
receptors (Miesfeld, 1989). The receptors are intracellular transcription factors which
exist in inactive apoprotein forms mainly in the cytoplasm of the cell. Upon ligand
binding, the receptors are activated and translocated into the nucleus where they can bind
effectively to a GRE site on DNA in form of a dimer and regulate transcription o f a
cis-linked gene (Miesfeld, 1995, Gehring, 1993, Tsai and O ’Malley, 1994).
Glucocorticoid receptor is a member o f superfamily o f steroid hormone receptors
which

include

the

receptors

for

glucocorticoid,

mineralocorticoid.

estrogen,

progesterone, androgen, thyroid, vitamin D, retinoic acid, and ecdysone (Carson-Jurica
et al., 1990, Tsai and O ’Malley, 1994). It also includes a number o f "orphan receptors"
which have gene sequence homology to the steroid hormone but the ligands for these
receptors are not known yet (Tsai and O'Malley, 1994).
The cDNA of GR from mouse, rat and human has been cloned and sequenced.
The human GR contains 777 amino acids. The receptors of mouse and rat origin are
slightly larger with 783 and 795 residues, respectively (Gehring, 1993),

Sequence

comparisons o f GR between these mammalian species have revealed that the GR-coding
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sequences are greater than 90 per cent identical, with the majority o f differences being
located to the variable amino terminal region (Miesfeld, 1995).
I.

Structural and Functional Domain of Glucocorticoid Receptor
Biochemical studies using partial proteolysis treatment have shown that

glucocorticoid receptors consist of three structural domains that coincide with three
discrete GR functions: transcriptional transactivation, specific DNA binding and
hormone binding (Reichman et al., 1984, Carlstedt-Duke et al., 1987, Rehmus et al..
1987, Chakraborti et al., 1992). Site-directed mutagenesis of GR cDNA within these
regions has shown that these domains can function independently of one another
(Giguere et at., 1986, Rusconi et al., 1987, Danielsen et al., 1987, Miesfeld, 1987).
Besides these three major functions which are related to the structural domains, a
number o f other functions and activities of the receptor have been identified and
localized in certain regions of the GR-coding sequence by means o f analysis o f amino
acid sequence and mutational dissection of intracellular receptors.

These include

residues required for receptor homodimerization (Wrange et al., 1989, Luisi et al., 1991,
Eriksson et al., 1990, Dahlman-Wright et al., 1991), nuclear translocation (Picard et al.,
1987, Cadepond et al., 1992), Hsp90 (90 KDa heat shock protein) interactions (Howard
et al.. 1990, Housley et al., 1990, Dalman et al., 1991), and residues for phosphorylation
(Bodw elletal., 1991).
The DNA binding domain is the most highly conserved region o f the receptor. It
is located roughly in the middle of the molecule and consists o f approximately 70 amino
acid residues. This domain is organized into two Cys-Cys zinc fingers resulting in a
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very specific folding o f the domain suitable for interaction with DNA (Gehring, 1993).
Biochemical and molecular genetic studies have revealed that several amino acid
residues in DNA-binding domain are important for receptor dimerization, and others are
important for specific DNA binding (Green, et al., 1988, Schena et al., 1989, Danielsen
et al., 1988, Zilliacus et al., 1991, Alroy and Freedman, 1992) as well as for
transcriptional transactivation (Schena et al., 1989, Hollenberg and Evans, 1988). The
specific amino acid residues which interact either with phosphate backbone of the DNA
or contact directly with bases in the DNA have been recognized (Miesfeld, 1995).
The ligand binding domain is located at the carboxyl end of GR consisting of
approximately 300 amino acids.

The amino acid sequence of this domain is also

conserved. Proteolytic digestion of the rat GR has revealed that an approximately 135
amino acid fragment of the hormone binding domain (residue 536-673) retains the
ability to specifically bind dexamethasone although the affinity is reduced (Chakraborti
et al., 1992, Simons et al., 1989). Two amino acid residues (Met622 and Cys656) within
this core region have been shown to contact dexamethasone (Simons et al., 1987,
Carlstedt-Duke et al., 1988). Point mutation studies on the hormone binding domain o f
mouse GR have revealed that additional residues appear to influence dexamethasone
binding (Danielsen et al., 1986, Byravan et al., 1991). Some of these mutations cause a
complete loss o f hormone binding (Glu546 to Gly and Cys742 to Gly), whereas others
decrease only the hormone binding affinity (Tyr770 to Asn and Pro547 to Ala). These
results suggest that ligand binding by the hormone binding domain requires a few critical
residues and a number o f other amino acids spread across the hormone binding domain
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that contribute weaker interactions with the hormone. It has been shown that ir Cys656
o f rat GR is mutated to either Gly or Ser residue, the ligand binding affinity of the
receptor is increased, leading to the creation of a "super" GR (Chakraborti et al., 1991).
Studies on the hormone binding domain of rat GR have revealed that this domain
is capable o f conferring hormone-dependent activity on a number of heterologous
proteins and functions as a regulatory module (Picard et al., 1988). One example of this
is that fusion of the GR hormone binding domain onto the adenovirus HI A
transactivation factor converted this otherwise constitutively active transcription factor
into a ligand-dependent regulator.

Moreover, when the hormone binding domain is

repositioned to the amino terminal end of GR, this backwards GR is still ligand
dependent for activity (Picard etal., 1988, Miesfeld, 1995).
Danielian and colleagues reported a putative transcriptional regulatory region
located in the mouse hormone binding domain. Double point mutations in mouse GR
which change Met758 and Leu759 to Ala residues, or Ile762 and Ile763 to Ala residues,
resulted in a greater than 90 per cent loss of transcriptional activity with little effect on
hormone binding (Danielian et al., 1992).
The amino-terminal domain occupies roughly the amino terminal half of the
receptor polypeptide.
(Gehring, 1993).

The amino acid sequences in this domain are less conserved

Functional mapping of the amino-terminal domain revealed a

sub-region of the GR amino-terminus which appeared to be involved in transcriptional
transactivation. This subdomain consists of approximately 200 amino acids and is called
taul (Giguere et al., 1986) or enh2 (Godowski et al., 1988). Deletion of this subdomain
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results in 90 per cent decrease in transactivation activity. This same region has been
shown to contain seven phosphorylated serine and threonine residues that have been
identified in the mouse GR (Miesfeld, 1995).
2.

Activation o f Glucocorticoid Receptor
Inactivated glucocorticoid receptor is part of a large complex (approximately 330

KDa), which appears to be a hetero-tetramer consisting of one receptor polypeptide, two
molecules of the Hsp90 and one molecule o f a 59 KDa protein (p59) (Gehring, 1993).
The receptor in the large complex does bind hormone ligand but is unable to interact
with DNA (Gehring, 1993). Hormone binding leads to activation o f the receptor and
dissociation o f Hsp90 and p59. The activated receptor is able to bind GRE site of the
target genes to enhance or inhibit gene expression at transcription level.

The

deactivation o f GR after a drop in glucocorticoid levels is referred to as "GR recycling"
or "nucleocytoplasmic shuttling" (DeFranco et al., 1991).
process is less understood.

The mechanism of this

After hormone dissociates from the activated GR, the

receptor is relocalized to the cytoplasm and presumably becomes reassociated with the
Hsp90/p59

complex

(Defranco

et al.,

1991).

It has

been

proposed

that

dephosphorylation o f GR by protein phosphatases may be an important regulatory
determinant of nucleocytoplasmic shuttling of the receptor (DeFranco et al.. 1991).
A number of studies have established that Hsp90 binds glucocorticoid receptor at
the site of the hormone binding domain (Pratt et al., 1988, Denis et al., 1988, Dalman et
al., 1991, Cadepond et al., 1991, Scherrer et al., 1993).

The binding o f Hsp90 to

glucocorticoid receptor is not only important in maintaining the receptor in an inactive
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state but is necessary to obtain the appropriate conformation required for hormone
binding activity of the receptor (Bresnick et al., 1989). Miesfeld (1995) suggested that
Hsp90 may facilitate proper folding of GR into an optimal conformation for ligand
binding.

Hsp90 associates with the GR at the termination of receptor translation

(Dalman et al., 1989). It is proposed that at the termination of translation the receptor
remains "docked" to Hsp90 and inactive. Upon ligand binding, the receptor undergoes a
conformation change, resulting in a disassociation of Hsp90 from receptor and an
activation of the receptor which is capable of binding to the GRE site of the target gene
and exerts its action of transcriptional regulation (Pratt, 1987). Hsp90 is also suggested
to be involved in protein trafficking across nuclear membrane (Pratt, 1993).
The

p59

protein

is a

member of immunophilin

proteins

that

bind

immunosuppressive agents with a high affinity and in a specific manner (Albers et al.,
1992). All of the members of the immunophilin protein family have peptidylprolyl
isomerase (PPIase) activity, and immunosuppressive agents bind to the PPIase site and
inhibit the isomerase activity. It is thought that the immunophilins may play major roles
in protein folding and trafficking in the cell (Walsh et al., 1992).
3.

Activities of Transcriptional Regulation of Glucocorticoid Receptor
The activated glucocorticoid receptors regulate gene expression at the

transcription level by binding to the glucocorticoid response elements (GRE) o f target
genes. The GR binds to the GRE as a dimer (Baniahmad et al., 1991). The sequence of
GRE is palindromic in which the half-site consensus sequence is TGTTCA. The spacing
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between the two GRE half-sites is optimal at three nucleotides for high-afTinity DNA
binding ofG R dimer (Luisi et al., 1991).
Several factors are thought to contribute to the specificity of GR interactions with
DNA and the regulatory activities o f GR on gene transcription (Miesfeld, 1995). First,
the number of GRE's and their positions relative to the transcriptional start site can have
a quantitative effect on the magnitude o f the glucocorticoid response. Jantzen and his
colleagues (1987) have demonstrated that two GREs (GRE II and GRE III) located
2.5 Kb upstream o f the transcription initiation site of TAT gene act cooperatively to
induce the gene expression. The proximal GRE (GRE III) has no function by itself to
stimulate transcription, whereas this element synergistically enhances glucocorticoid
induction o f gene expression when it is present in conjunction with the distal GRE
(GRE II). The GRE II alone displays only 30% o f the induction in comparison with the
effect o f both elements. They have also demonstrated that the inducibility increases
approximately 4-fold when the fragment containing elements II and III is moved closer
to the promoter.
Second, accessibility of the DNA to GR binding could be modulated by
chromatin structure, DNA methylation, or nuclear attachment sites.

It has been

suggested that chromatin structure could regulate the number o f accessible sites as an
early step in controlling gene activity (Wolffe, 1990). It has also been suggested that
cytosine methylation at CpG dinucleotides, the main modification o f vertebrate DNA.
has a potential role in the regulation of gene expression due to the evidences that
hypomethylation o f promoters is correlated in general with gene activity and, conversely.
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de novo methylation is associated with the silencing of the sequences (Doerfler, 1983,
Cedar, 1988). However, Weih and colleagues (1991) have demonstrated that in vivo
demethylation of cytosine residues upstream o f the tyrosine aminotransferase gene in rat
fibroblast XC cells does not result in GR-mediated transcriptional activation, indicating
that CpG methylation is not the sole mechanism in preventing access o f a protein to
DNA. It is suggested that higher-order chromatin structure may be more critical than
DNA methylation with regard to GR binding to GRE's (Miesfeld, 1995).
Third, other transcription factors may interact with GR and thereby affect the
regulatory activities of GR (Miner et al., 1991, Schule et al., 1991). These transcription
factors could be additional DNA binding proteins or adaptor molecules that are able to
enhance glucocorticoid responsiveness. If these factors are expressed in only a subset o f
cell types, they could be important modulators of celt-specific responses.
It has been established that the synergistic action of GR with other transcription
factors exerts a greater effect on induction of gene expression than the additive effects o f
either factor acting singly (Pan and Koontz, 1995). This synergistic action has been
supported by a number o f studies. For example, the GRE at about -2.5 Kb of the TAT
gene is adjacent to a CCAAT element, a CACCC element, and binding sites for the
liver-specific proteins HNF-3 and C/EBP.

It has been shown that binding of

transcription factors to these elements provide synergistic functions for transcription of
gene induction by glucocoticoids. (Becker et al., 1986, Reik et al., 1991, Rigaud et al.,
1991, Grange et al., 1991, DeVack et al., 1993, Nitsch et al., 1993a).

In the

phosphoenolpyruvate carboxykinase (PEPCK) promoter, a glucocorticoid responsive
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unit (GRU) which is located in the upstream region from -451 to -351 contains two
GREs, two accessory factor elements and a CREB binding site.

It has been

demonstrated that the full glucocorticoid induction of PEPCK gene requires the presence
o f all the elements at this GRU region (Imai et al., 1990, 1993, Hall et al., 1995).
Moreover, combinations of a synthetic GRE contiguous with binding sites for other
transcription factors such as the CACCC-box factor, NF-1, CCAAT-box factor, Sp-1,
and Oct-1 have been reported to activate gene expression in a synergistic and
cell-specific manner (Schule et al., 1988).
Evidence of cell-type specific transcription factors that modulate GR function
has also been demonstrated.

For example, the PEPCK gene is induced by

glucocorticoids in the liver and kidney but is repressed by glucocorticoids in adipose
tissue (Nechushtan et al., 1987). Analysis of GR-regulated transcription o f PEPCK in
liver and adipocyte cells revealed that the same promoter is used in both cell types.
Other examples are that the TAT gene is expressed and GR-regulated in the liver but not
in pituitary cells (Grange et al., 1991), whereas the growth hormone gene is expressed in
pituitary cells but not liver cells. All these data suggested that the transcription factors
other than GR are important in regulation o f glucocorticoid-induced gene expression.
The activated glucocorticoid receptors either positively or negatively regulate
gene expression in target cells. Some genes are transcriptionally induced by GR, such as
TAT gene and PEPCK gene. Others are repressed by GR, such as proopiomelanocortin
(Drouin et al., 1989, 1993) and prolactin genes (Sakai et al., 1988).

GR activates

transcription of a gene possibly by stimulating the assembly o f the preinitiation
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transcription complex or stabilizing the complex near the transcription start site which
allows efficient transcription initiation by RNA polymerase II (Wahli and Martinez,
1991).

Several mechanisms have been proposed to be involved in transcriptional

repression of genes by GR. One proposed mechanism is that a negatively acting factor
binds to a sequence adjacent to or overlapping the binding site for GR, and prevents the
binding of GR by steric hindrance (Truss and Beato, 1993, Clark and Docherty, 1993).
The other proposed mechanism is that a negative glucocorticoid responsive element
(nGRE) is present in the target gene. The nGRE diverges from the GRE consensus
sequence but as few as two site-directed alterations of the nGRE were sufficient to
convert it to a positive GRE (Diamond et al., 1990). It is suggested that the interaction
o f receptor with nGRE might alter receptor conformation, thereby inhibiting its positive
activity (Sakai, et al., 1988, Guertin et al., 1988, Drouin et al., 1993).
In addition to these two mechanisms, a more complicated mechanism which
involves regulation of gene expression by GR has been proposed. A number o f studies
provide evidence that transcription regulation is mediated by cross-talk between two
signaling pathways. The best example of this is the cross-talk between the GR system
and the Fos/Jun signaling pathway through transcriptional interference (Jonat et al.,
1990, Yang-Yen et al., 1990, Schule et al., 1990).

It has been reported that

overexpression of Jun blunts GR-mediated gene expression, and over expression of the
GR can block AP-1 gene activation. Formation of GR/Jun heteromeric complexes may
prevent the limiting transcription factor from forming its normal, active dimeric complex
(Vig et al., 1994).

In a "composite" GRE the formation o f GR/Jun/Jun complex
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stimulates gene transcription over that obtained with a Jun/Jun dimer itself, while the
binding of the GR to a Fos/Jun complex inhibits the transcription rate of a gene that is
stimulated by a Fos/Jun complex (Diamond et al., 1990). Furthermore, a study reported
by Maroder et al. (1993) suggested that Jun and Fos may differentially (positively or
negatively) modulate GR activity on simple GREs, depending upon the cell type
involved.
The example of the inhibition of glucocorticoid-induced gene expression by
another signal transduction pathway is the transcriptional regulation o f TAT gene. Reik
and colleagues (1994) have demonstrated that the second messenger pathway leading
from protein kinase C to the transcription factor AP-1 by the phorbol ester
12-O-tetradecanoyl-phorbal-13-acetate (TPA) impairs induction of the TAT gene both
by glucocorticoid hormone and cAMP (Reik et al., 1994).

TPA has no effect on

glucocorticoid induced changes o f chromatin structure at -2.5 enhancer region of TAT
gene and no effect on GR binding to the TAT GRE or on binding of other factors
recruited to the -2.5Kb enhancer of the TAT gene after glucocorticoid induction.
Whereas, TPA-dependent changes in chromatin structure between the enhancer and start
site o f transcription were seen. These data indicate that TPA inhibition of glucocorticoid
induction appears to lie with interference between the glucocorticoid-dependent
enhancer and the TAT gene promoter (Reik et al., 1994). In contrast. TPA inhibition of
cAMP induction of TAT gene correlates with reduced occupancy o f the cAMP response
element in vivo. Cross-talk regulation of the PEPCK gene appears to be similar to that
o f the TAT gene (Chu and Granner, 1986, O’Brien et al., 1991, Gurney et al., 1992).
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In contrast to the inhibition of glucocorticoid-induced gene expression by another
signal transduction pathway, glucocorticoids could repress the gene expression induced
by a different signal transduction pathway. One example of this is the transcriptional
regulation of glucocorticoid receptor and c-jun genes (Vig et al., 1994). By studies on
the molecular mechanism of glucocorticoid receptor autoregulation, Vig and colleagues
(1994) have demonstrated that cross-talk between the GR and AP-I signaling pathways
is important in the autologous down-regulation of GR levels.

A coordinate

down-regulation of GR and c-jun mRNA levels has also been demonstrated. Analysis of
promoter sequence of GR revealed that a putative AP-I site, which differs by only one
nucleotide from consensus AP-1 site, was present in GR promoter. This putative AP-1
site appears not to be a composite GRE. Deletion analysis suggests that this site is
important in the hormone-mediated down-regulation of GR gene. In the c-jun promoter
there is a consensus AP-I site which is important for the autostimulatory effect on c-jun
gene expression. Comparison o f GR promoter with c-jun promoter shows that the AP-1
site is the only regulatory element that is common in both. It has been proposed that
these two genes are stimulated by AP-1 transcription factors (Fos/Jun or Jun/Jun
dimers). The ligand-bound glucocorticoid receptor may form a heteromeric complex
with Jun. Formation of the GR/Jun heteromeric complex could deplete the nuclear level
o f Jun protein, and thus reduced the effective concentration of Fos/Jun (or Jun/Jun) AP-1
transcriptional activator complexes.

As a result, both GR and c-jun gene are

coordinately down-regulated. Glucocorticoid induced gene repression in this case is
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mediated through protein-protein interaction between GR and other transcription factor
rather than the interaction of GR to the DNA element.
4.

Subtypes of Glucocorticoid Receptor
There are two types o f glucocorticoid receptors: type I mineralocorticoid receptor

and type II glucocorticoid receptor (York, 1992). The natural glucocorticoids, cortisol
and corticosterone, have much higher affinity for mineralocorticoid than glucocorticoid
receptors (Howard et al., 1990, Housley et al., 1990).

In peripheral tissues, the

concentrations of glucocorticoids are 10-100 fold greater than aldosterone. The binding
o f glucocorticoids to the mineralocorticoid receptor is thought to be prevented by the
presence of 11-hydroxysteroid dehydrogenase which converts glucocorticoid into an
oxidized keto-form.

This oxidized keto-form glucocorticoid no longer binds to the

mineralocorticoid receptor (Moisan et al., 1990). In contrast, as brain tissue contains
relatively

little

11-hydroxysteroid

dehydrogenase

activity,

glucocorticoids

are

consequently able to bind to both type 1 and type II glucocorticoid receptors in the
majority of brain regions (DeKloet and Reul, 1987, Reul et al., 1987, York, 1992).
Although there are fewer type I receptors than type II receptors in the brain, the type I
receptors are fully occupied at physiological levels o f glucocorticoids (York, 1992). It
has been suggested that actions of glucocorticoids within the central nervous system to
regulate metabolism, feeding behavior, autonomic activity and stress responses may be
modulated through interactions with both type I mineralocorticoid receptors and type II
glucocorticoid receptors(York, 1993).
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Glucocorticoid* and Animal Models of Genetic Obesity
The effects of glucocorticoids on regulation of energy balance and promoting fat
deposition are observed in patients with Cushing's syndrome and Addison's disease.
Hypersecretion of glucocorticoids in patients with Cushing's syndrome results in extra
deposition of fat in the thoracic and upper abdominal regions o f the body, while lack of
adequate glucocorticoid secretion in patient with Addison's disease makes the patient
always thin (Vander etal., 1990, York, 1992, 1993).
The effects of glucocorticoids on promoting fat deposition has also been
recognized by studies on experimental models of obesity. A number of studies have
demonstrated that the development of animal obesity, such as genetic, hypothalamic,
dietary, endocrine and viral origin o f animal obesity, is dependent on adrenal
glucocorticoids. Studies on Zucker fa/fa rat, a genetic model of animal obesity, have
demonstrated that adrenalectomy prevents the further development of obesity (Bray et
al., 1979, 1989, 1990, York, 1989, lonescu et al., 1988), while treatment of
adrenalectomized fa/fa rats with glucocorticoid analog, such as dexamethasone, restores
the obesity as well as the abnormalities associated with this obese syndrome (Planche et
al., 1983, York, 1989, Freedman et al., 1985).
The effects o f glucocoticoids on the development of obesity have been revealed
through the actions o f the glucocorticoids on both central nervous system and peripheral
tissues. As mentioned previously, the central glucocorticoid actions in controlling body
energy stores may be modulated either directly or indirectly through their ability to
regulate the production or secretion o f other peptides or hormones (York, 1993). Studies
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on experimental models of obesity suggested that the reciprocal changes in CRH or other
neuropeptides could be responsible for some of the glucocorticoid effects. CRH is a
potent stimulator of sympathetic activity and is capable of inhibiting food intake.
Chronic infusion o f CRH into the cerebral ventricles of obese rats suppresses food
intake, enhances brown adipose tissue thermogenesis, reduces insulin secretion, and
either prevents the further development o f obesity or leads to some reduction in body
weight and body fat (Holt and York, 1989, Langhans et al., 1991, Arase et al., 1988). It
seems that the hyperphagia, reduced sympathetic drive to BAT and the enhanced vagal
stimulation of pancreatic p-cells in obese rat are all consistent with a reduced CRH
activity (Stubbs and York, 1991, Arase et al., 1988, Holt and York, 1989, Brown and
Fisher, 1985, York, 1993). The physiological effects of adrenalectomy in obese rats may
also be explained by the increased level of CRH produced when the feedback signal of
corticosterone is removed. However, the basal or stimulated CRH level in hypothalamus
o f obese rats was normal or even elevated in comparison with lean rats (Plotsky et al.,
1992, Bestetti et al., 1990), suggesting that the feedback regulation of glucocorticoids to
the hypothalamic-pituitary-adrenal axis is abnormal in obese rat.
In addition to inhibitory regulation of CRH
Glucocorticoids

also

negatively

regulate

the

synthesis and secretion.

synthesis

and

secretion

of

proopiomelanocortin (POMC), a precursor for several pituitary and hypothalamic
peptide hormone (York, 1993). Adrenalectomy leads to increased secretion o f ACTH.
endorphins, melanocyte-stimulating hormone and other peptides of the POMC family
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(Drouin et al., 1987, Harlan, 1988). The presence o f excessive ACTH secretion in the
obese fa/fa rat (Yukimura et al., 1978) despite high circulating corticosterone levels
suggests that the feed back control of glucocorticoids on POMC transcription and/or
post-translational processing is abnormal. Thus, it is possible that peptides of the POMC
system are involved in both the regulation of obesity and the restoration o f normal
energetic efficiency after adrenalectomy (York, 1993).
It has also been reported that central actions o f glucocorticoids may enhance
vagal drive to the pancreatic B-cells of the Zucker fa/fa rats and lead to an enhanced
insulin secretory response under basal and stimulated conditions (York, 1993).
Considerable experimental evidence has demonstrated that obese Zucker rats have high
basal insulin levels and excess secretion of insulin in response to an intravenously (i.v.)
glucose load.

Atropine pretreatment o f obese rats reduced basal insulin levels and

stimulatory insulin secretion. It has also been demonstrated that the basal insulin and the
glucose stimulated insulin secretion are reduced in adrenalectomized obese rats.
Infusion of dexamethasone into the third ventricle o f adrenalectomized obese rats for
seven days resulted in an increased basal insulin secretion as well as the increased
response of insulin secretion to the iv glucose load. This glucose-stimulated insulin
secretory response was again blocked by atropine, implying that central dexamethasone
had restored the vagally mediated components of insulin secretion to these animals
(York, 1993). On the other hand, CRH infusion into the third ventricle o f obese rats
with intact adrenals reduced both basal insulin secretion and insulin secretory response
to iv glucose. It has thus been suggested that glucocorticoid actions in central nervous
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system may regulate vagal drive to the pancreas through direct or indirect regulation o f
CRH secretion and the vagal axis is overactive in the obese Zucker rats because o f a
glucocorticoid-mediated action (York, 1993).
All these experimental observations suggest that the glucocorticoids may act
centrally to regulate the development o f obesity. However, the adrenalectomized obese
rats infused centrally with dexamethasone did not develop obesity. This suggests that
central glucocorticoid activity alone cannot restore obesity (York. 1993). It appears that
the development of obesity is associated with excessive or abnormal glucocorticoid
responsiveness in both central nervous system and in numerous peripheral tissues.
Indeed, the excessive glucocorticoid response in peripheral tissues has been observed in
obese Zucker rats. For instance, the levels of mRNA for GAPDH and ME in liver and
adipose tissue were increased in obese rats.

Adrenalectomy markedly reduced the

mRNA for GAPDH and ME in Zucker fatty rats to the low levels observed in
adrenalectomized lean rats.

Corticosterone treatment induced a larger and earlier

increase in mRNA levels in adrenalectomized obese rats than adrenalectomized lean rats
(Bray et al„ 1991). The mRNA levels of TAT gene was also increased in obese rats
(Jenson et al., 1995). This is coincident with the previous observations that the activity
and protein levels of hepatic TAT were increased in obese rats. The increased hepatic
TAT mRNA in obese rats was abolished after adrenalectomy and partially restored
within 24 hours of corticosterone treatment (Jenson et al., 1995). These data suggested
that in peripheral tissues a group of genes may be abnormally regulated by
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glucocorticoids at the transcriptional level and the underlying defect in glucocorticoid
control is widely expressed and not just located in CNS.
The glucocorticoid effects are mediated through glucocorticoid receptors at both
peripheral and CNS sites. As mentioned before, there are two types of glucocorticoid
receptors (type I mineralocorticoid receptor and type II glucocorticoid receptor), and the
concentration of glucocorticoids is 100 fold than that of aldosterone.

Moreover, the

absence of 11 -hydroxysteroid dehydrogenase in the CNS allows glucocorticoids to bind
to type 1 receptors. In peripheral tissue, glucocorticoid effects are mediated through type
(I receptors, while in CNS, the glucocorticoid effects on energy balance and
development of obesity are mediated through both type 1 and type II receptors.
Devenport and colleagues (Devenport et al., 1991, 1989, 1984) have suggested from
studies of adrenalectomized lean rats that the anabolic effects of glucocorticoids in
promoting fat deposition are indeed expressed through binding to type I receptors, as
they can be mimicked in their studies by aldosterone. They further suggested that type II
GR receptor activity is associated with the catabolic effects of corticosterone, while York
and colleagues (York, 1993) suggested that type I) GR rather than type I MR receptors
were required for the development o f obesity. They used the type II receptor antagonist,
RU 486, to block type II receptor mediated glucocorticoid activity in both genetic and
dietary models o f obesity. It has been demonstrated that the obesity of the young Zucker
fatty rat was not only prevented but reversed by RU486 (Langley and York, 1990).
Treatment of obese rats with GR antagonist RU486 not only reduced body fat deposition
but also increased protein deposition. Body composition at the end of treatment period.
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as shown by chemical analysis, was identical in lean and obese rats irrespective of their
genotype. It has also been demonstrated that this effect o f RU486 was not specific to the
genetic obesity of Zucker rats. Osbome-Mendel rats, when fed high fat diet, develop a
moderate obesity but stay relatively lean when fed a high carbohydrate diet.

RU486

reversed the obesity in Osbome-Mendel rats fed a high fat diet, but had very little effect
on body weight or body composition of Osbome-Mendel rats fed a high carbohydrate
diet (Okada et al., 1992). Similarly, RU486 had very little effect on lean Zucker rats
(Langley and York, 1990). These observations suggest that in both genetic and dietary
forms o f obesity, the rats were very responsive to blockade o f GR receptors, whereas
their lean control littermates showed little change in body weight or body composition in
response to RU486. It is apparent that obesity in these animals is associated with a
sensitivity to glucocorticoid receptor blockade that is not present in lean rats (York,
1993).
Studies on obese Zucker rats have shown that the Zucker fa/fa rat is, in fact,
hyper-responsive to the effect of corticosterone (York, 1989, Freedman et al., 1985).
Unlike obese (ob/oh) and diabetes (<db/db) mice, the changes in corticosterone levels in
obese /a^/a rats are moderate. In young obese fa/fa rats, circulating corticosterone and
diurnal variation in corticosterone levels appear to be normal (Shargill et al., 1983).
With the increase of age, there is only a small increase in corticosterone levels and a
gradual loss o f the diurnal rhythm (Martin et al., 1978). The ACTH levels are elevated
(Yukimura et al., 1978) while CRH levels are either low or normal in obese rats
(Nakaishi et al., 1990, Bestetti et al., 1990). Corticosterone turnover is enhanced but

whole brain, hypothalamic, and hippocampal corticosterone concentrations are unaltered
(Cunningham et al., 1986). These minor changes in corticosterone levels cannot explain
the obesity.

In addition, adrenalectomy of obese rats prevents the development of

obesity and replacement o f adrenalectomized obese rats with glucocorticoids restored
obesity. In contrast to that o f obese rats, the adrenalectomy of lean rats only caused
small changes in food intake, energy balance, sympathetic activity and insulin secretion.
Replacement o f adrenalectomized lean rats with glucocorticoid hormone did not lead to
the development o f obesity (Bray and York, 1979, Bray et al., 1990, Shargill et al., 1983,
Guiltaume-Gentil et al., 1990). Moreover, the obesity of the young Zucker fatty rats was
prevented or even reversed by use of RU486 but this sensitivity of glucocorticoid
receptor blockade was not present in lean rats. Furthermore, the mRNA levels of TAT
MB and GAPDH genes were markedly reduced in Zucker fatty rats by adrenalectomy
and showed a dose and time dependent increase after corticosterone replacement,
whereas glucocorticoid status had a much smaller effect on the mRNA levels of TAT
ME and GAPDH genes in lean rats (Bray et al., 1991, Jenson et al., 1995). The excess
response to glucocorticoids in obese rats has been demonstrated at several organizational
levels ranging from whole body composition that is excess body fat deposition (Altars et
al., 1987, Freedman et al., 1986), through physiological systems such as feeding
behavior, insulin secretion and BAT function (Freedman et al., 1986, Castonguay et al.,
1983), to the activity of specific proteins such as lipoprotein lipase and lipogenic
enzymes (Greenwood, 1985, Fletcher, 1986), and the levels o f specific mRNAs (Bray et
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Tyrosine Aminotransferase
1.

Tyrosine Aminotransferase Gene and Upstream Region
Tyrosine aminotransferase (TAT) gene is expressed in a tissue-specific and

hormone-regulated manner (Nitsch et al., 1993a). The 2.4-kilobase-long TAT mRNA is
encoded by a gene that extends over 11 kitobases (Kb) and is interrupted by 11 introns
(Shinomiya et al., 1984). The TAT upstream region, which is involved in regulation of
tissue-specific and hormone-inducible gene expression, has been extensively studied.
Over the last several years, a total of seven cis-acting elements have been identified
(Lobanenkov et al., 1989, Jantzen et al., 1987, Oshima and Simons, 1992, Szapary et al.,
1992, 1993). These elements are all located upstream of the transcription initiation site.
Five o f these cis-acting elements are located at -11, -5.5, -3.6, -2.5, -0.1 Kb respectively.
The other two are located in the region between -2.56 and -2.3 Kb and the region
between -2.95 and -2.56 Kb. The transacting factors bind to these cis-acting elements to
increase or repress the gene expression.
The element at -11 Kb is a tissue-specific enhancer which is suggested to be
important during development (Nitsch et al., 1990). The cis-acting element at -3.6 Kb is
a cAMP-responsive enhancer which consists of a cAMP responsive element (CRE) in
combination with a binding site for HNF-4 (Boshart et al., 1990, Weih et al., 1990,
Nitsch et al., 1993a). The CRE and HNF-4 binding site act synergistically to confer
liver-specific and cAMP inducible activity (Nitsch et al., 1993b).

Mutations in the

HNF-4 binding site, which is juxtaposed by a CRE in a reconstituted heterologous
promoter, affect the DNA binding of HNF-4, resulting in reduced basal as well as
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cAMP-induced activities o f transcription. The CRH within the -3.6 Kb enhancer, in
addition to the cAMP-inducible activity, also mediates the negative effect o f insulin on
cAMP-induced TAT gene transcription (Ganss et al., 1994). The cis-acting element at
-0.1 Kb may contribute to cell type-specific basal level of TAT gene expression (Becker
et al., 1987). The element at the region o f -2.56 to -2.31 Kb is a tissue-selective element
which represses glucocorticoid induced TAT gene expression in non-hepatic cells
(Szapary et al., 1993).

The cis-acting element in the region of -2.95 to -2.56 Kb,

however, regulates glucocorticoid-induced gene expression in a tissue-nonselective
manner, as it represses the absolute level o f glucocorticoid-induced gene expression at
both hepatic and nonhepatic cells (Szapary et al., 1993).
Two glucocorticoid responsive units (GRUs) are located at -2.5 Kb and -5.5 Kb
o f TAT gene respectively (Jantzen et al., 1987, Grange et al., 1989, Nitsch et al., 1990).
The -2.5 Kb GRU corresponds to a glucocorticoid-dependent DNase I-hypersensitive
site (Becker et al., 1984, Grange et al., 1989) that results tfom the displacement or
alteration o f two specifically phased nucleosomes (Carr and Richard-Foy. 1990),
whereas the -5.5 Kb GRU corresponds to a glucocorticoid-independent DNase I
hypersensitive site (Grange et al.. 1989).

It has been demonstrated that full

glucocorticoid induction of the rat TAT gene is achieved through cooperative interaction
o f these two GRUs. In the -2.5 Kb GRU, there are three GR-binding sites, termed GRE
I, II and III (Jantzen et al., 1987), whereas in the -5.5 Kb GRU there is a single
GR-binding site (Grange et al., 1989).

These GR-binding sites are associated with

multiple contiguous and overlapping binding sites for other trans-acting factors; several
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o f them are expressed preferentially in liver cells (Espinas et al., 1994). Many o f these
transcription factors belong to families of C/EBP and HNF3 as well as Ets
protooncogenes (Grange et al., 1989, Espinas et al., 1994)
By studying the GREs at -2.5 Kb of TAT gene, Jantzen and colleagues (1987)
have demonstrated that GRE I (from -2614

to -2598 bp) does not contribute to

glucocorticoid inducibility, although it is capable of binding the receptor in vitro. A
possible explanation for the inactivity o f this sequence is that this homology is shortened
in comparison to other two sites and represents only one-half of the palindromic
sequence characteristic of functional GREs. Analysis o f mutants deleting elements II
and III, alone or together, have shown that both elements arc required for maximal
glucocorticoid induction of the transcription of the TAT gene and that they have a strong
synergistic effect on promoter activity.

GRE II (from -2510 to -2490 bp) alone is

capable of eliciting about one-third of the maximal response to glucocorticoid induction
whereas GRE III (from -2454 to -2422 bp) by itself is inactive (Jantzen et al., 1987). It
is unclear why element III alone is not functional. It may be related to the fact that the
palindromic sequence of GRE III is not well conserved so that GR is not capable of
binding to site of GRE IN in the absence of the GRE II site. Binding o f glucocorticoid
receptor at GRE II may facilitate the binding of GR to the GRE III site.

However,

changes in dimethyl reactivity in vivo following hormone administration, which are
characteristic of receptor-DNA interaction, argue that the receptor interacted with
element 111 (Becker et al., 1986). It can not be excluded either that a protein other than
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the receptor binds at the sequence of element III interacting with the receptor bound to
element II (Jantzen et al., 1987).
Recent studies on GRU at -2.5 Kb o f TAT gene have demonstrated that there are
several cis-elements which are bound by trans-acting factors other than glucocorticoid
receptors in this region (Espinas et al., 1994, Nitsch et al., 1993a, Rigaud et al., 199]).
Some o f these elements are adjacent while others are overlap each other thus that the
interactions of these factors are mutually exclusive (Rigaud et al.. 1991). When distinct
trans-acting factors compete for overlapping binding site in vitro, it is tempting to
speculate that one negatively regulates the action of the other (Renkawitz. 1990).
However, in some cases, it has been shown that both factors can activate transcription
(Bruggemeier et al., 1990, Lemaigre et al., 1990, Schaufele et al., 1990).
Using in vivo DNase I footprinting, Rigaud and colleagues (1991) have
demonstrated that there are two HNF-5 binding sites at -2.5 Kb GRU region. One of the
sites overlaps with GRE III.

The HNF-5 factors bind within 10 min of hormone

addition, indicating that they participate in transcription activation.

They have also

demonstrated that glucocorticoid-dependent HNF-5 binding could be detected at both
sites even though one of them is incompatible with glucocorticoid receptor binding, fhe
binding o f HNF-5 occurs where there is a glucocorticoid-dependent disruption of
nucleosomal structure.

Therefore, they proposed a hit-and-run mechanism of

transcriptional activation by glucocorticoid receptor: "the activated receptor binds its
target sequence, modifies local chromatin structure, then leaves its site accessible to
another factor."
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Nitsch and colleagues (1993a) reported that the liver-enriched protein HNF-5 is
possibly identical to HNF-3, since the HNF-3 binding site that they identified coincides
with one of the two putative HNF-5 motifs described in the TAT enhancer at -2.5 Kb
region and displays a methylation interference pattern identical with that for HNF-5.
Moreover, the second postulated HNF-5 binding site also interacts with HNF-3 proteins.
They have also demonstrated that one HNF-3 binding site overlaps with the GRE in the
glucocorticoid inducible TAT enhancer at -2.5 Kb, at a sequence motif which was
previously characterized as GRE III (Jantzen et al., 1987, Becker et al., 1986) and it
interacts with three liver-enriched proteins HNF3a, -B, and -y. I.ike the HNF-4 binding
site at -3.6 Kb cAMP-responsive enhancer o f TAT gene, the HNF-3 motif and the GRE
act synergistically to confer liver-specific and hormone-inducible TAT gene activity
(Nitsch et al., 1993a). This same HNF-3 motif is also the target site for insulin-mediated
repression of the glucocorticoid-inducible TAT gene expression (Ganss et al.. 1994). In
addition to the motif at -2.5 Kb, the HNF-3 binding site has also been found at -5.5 Kb
and -11 Kb of the TAT gene (Rigaud et al., 1991, Nitsch, 1993a).
It has been reported that two binding sites for members of the Ets family of
transcription factors are located in the -2.5 Kb GRU of the TAT gene (Espinas et al.,
1994). The Ets proto-oncogene family is one o f the most recently identified class of
eukaryotic sequence-specific DNA-binding proteins that contains already more than 10
different members (Gutman and Wasylyk, 1991, Macleod et al., 1992, Wasylyk et al..
1993). Ets proteins bind specifically to purine-rich DNA sequence, and a number of
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them function as transcriptional regulators (Wasylyk et al., 1993). Ets family members
have been implicated in various developmental processes and in the response o f cells to
a variety o f extracellular signals (Wasylyk et al., 1993). It has been shown that one o f
the two Ets binding sites at -2.5 Kb o f TAT gene overlaps with GRE II, whereas the
other is located in its vicinity (Espinas et al., 1994). Inactivation of the latter binding site
leads to a two fold reduction of the glucocorticoid response, whereas inactivation of the
site overlapping GRE II has no detectable effect. In vivo footprinting analysis reveals
that the active site is occupied in a glucocorticoid-independent manner and the inactive
site that overlaps the GRE II is not occupied. However, this inactive site that overlaps
the GRE II can confer Ets-dependent stimulation of both basal and glucocorticoid
induced levels o f transcription when it is removed from the GRU and duplicated. It is
suggested that these Ets-binding sites could participate in the integration of the
glucocorticoid response of the TAT gene with signal transduction pathways triggered by
other nonsteroidal extracellular stimuli (Espinas et at., 1994). Espinas and colleagues
have also demonstrated that the combined action of HNF3 and Ets factors is necessary
for the activity o f this GRU element. When either the Ets sites or the HNF3 sites are
mutated, the glucocorticoid response decreases. When the four mutations are combined,
there is almost no response left (Espinas et al., 1994).
2.

Activity of Tyrosine Aminotransferase in Obese Zucker Rat
Tyrosine aminotransferase is a rate limiting enzyme o f hepatic tyrosine

catabolism. The activity of TAT increased in young fatty rats despite normal circulating
concentration of corticosterone (Shargill et al., 1988). The increased activity of TAT is
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associated with a parallel increase in enzyme concentration within the liver cell (Shargill
et al., 1983).

Northern blotting analyses (Jenson et al., 1995) have shown that the

mRNA level of hepatic TAT gene increased in obese Zucker rats and this increased
mRNA level was abolished after adrenalectomy and partially restored within 24 hours of
corticosterone treatment. However, glucocorticoids have much less effect on the mRNA
level o f the TAT gene in lean rats. These data suggest that the hepatic TAT gene is
hypersensitive to the glucocorticoid regulation.
As a result of the increased activity of TAT, the concentration of tyrosine, a
precursor of catecholamine neurotransmitter, decreased in liver as well as brain o f the
obese rat but normalized after adrenalectomy (Shargill et al., 1983). The changes in
tyrosine concentration may be relative to the disturbances in norepinephrine
concentrations and hypothalamic function of obese rats (Bray and York, 1979, Cruce et
al., 1976).
The increased activity of TAT may also relate to an imbalance between protein
and lipid deposition in obese fatty rats. It has been demonstrated that the young weaned
obese rat had a higher fractional rate of muscle protein breakdown as well as an increase
in liver amino acid degradation (Dunn et al., 1980), resulting in an increase in carbon
flux from amino acids into lipid and a reduced incorporation of amino acid carbon into
protein (Dunn et al., 1980).

MATERIALS AND METHODS
Animals
Zucker lean and obese rats from two sources have been used in the described
experiments.

Zucker obese {fa/fa) and lean (Fa^fcr or Fa/Fa) rats were bred from

heterozygote parents.

Zucker X Brown Norway cross colony with identified

homozygous lean (Fa/Fa) and obese (fa/fa) genotype were also used.

This cross

provides a restriction fragment length polymorphism close to the fa gene that allows
determination o f the number offa genes carried with an error of less than 1% (Truett et
al. 1995). Animals used for gel retardation assay are listed on Table 1 and Table 2.
Animals used for northern blot analysis are listed on Table 3.
All rats were bred in the AALAC-accredited animal facility of the Pennington
Biomedical Research Center. They were housed, after weaning at 21 days, in hanging
wire cages with an automated water system in rooms maintained at 22-24°C with a 12
hours (8:00 to 20:00) light-dark cycle. Food was available ad libitum.

Adrenalectomies and Dcxamethasone Replaced Treatment
Bilateral adrenalectomies or sham-operations of both lean and obese rats were
performed under metofane anesthesia. Adrenalectomized rats were housed singly under
the same condition as mentioned previously except that 0.9% saline (W/V) drinking
solution instead of water was supplied. Five days after adrenalectomy some rats were
replaced with dexamethasone (0.5mg/Kg body weight) twice (once per every morning)
before sacrifice of the animals.
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Table 1.
Date
6/92

mi
12/92
1/93
7/93
7/93
3/94
3/94
3/94
3/94
3/94
3/94
3/94
3/94
7/94
7/94
8/94
8/94

Animals Used for Gel Retardation Assay.
Species
Zucker
Zucker
Zucker
Zucker
Zucker
Zucker
ZBN
ZBN
ZBN
ZBN
ZBN
ZBN
ZBN
ZBN
Zucker
Zucker
Zucker
Zucker

Age
4W
4W
4W
4W
4W
4W
12W
12W
12W
4W
4W
4W
7W
7W
7W
7W
5W
5W

Genotype
+/+ or fal+
faifa
+/+ or fal+
faifa
+/+
faifa

Male
3
2
4
3
9

faifa
fa!+
+/+
faifa
fal+
+/+
faifa
+/+
+/+ or fal+
faifa
+/+ or fal+
faifa

2
2
1
2
2
2
1
1

ZBN: Zucker X Brown Norway cross.

*

-

2
2

Female
3
2
4
4
5
6
-

1

1
1
-

3
3
-

Liver
whole
whole
whole
whole
whole
whole
partial
partial
partial
partial
partial
partial
whole
whole
whole
whole
partial
partial

Nuclear Extract
pooled
pooled
pooled
pooled
pooled
pooled
pooled
pooled
-

pooled
pooled
pooled
-

-

Table 2.
Date
12m
12m
12m
12m
12m
12m

Adrenalectomized Animals Used for Gel Retardation Assay.
Species
Zucker
Zucker
Zucker
Zucker
Zucker
Zucker

Age

6W
6W
6W
6W
6W
6W

Genotype
+/+ or/a/+
faifa
+/+ or fai+
faifa
+/+ or fa!+
faifa

Sex
F
F
F
F
F
F

Operations*

Sham:
Adx:
Adx/Dex:

Table 3.

Animals Used for Northern Blot Analysis.

Date
3/95
3/95
3/95
3/95

Species
Zucker
Zucker
Zucker
Zucker

No.

2
2
2
2
2
2

Operations*
Sham
Sham
Adx
Adx
Adx/Dex
Adx/Dex

Liver
partial
partial
partial
partial
partial
partial

Nuclear Extract
pooled
pooled
pooled
pooled
pooled
pooled

Sham-operation.
Adrenalectomy.
Adrenalectomized and then treated with dexamethasone replacement.

Age
7W
7W
7W
7W

Genotype
+/+ or fal+
faifa
+!+ or fal+
faifa

Sex
F
F
F
F

No.
1
1
1
1

Liver
partial
partial
partial
partial

46

Chemicals, Reagents and Enzymes
Dithiothreitol (DTT), 5-bromo-4-chloro-3-indolyl-B-D-galactoside (X-Gal) and
phenytmethyl sulfony Ifluoride (PMSF) were purchased from GIBCO-BRL. Isopropyl
thio-O-D-galactoside (IPTG) was purchased from FisherBiotech.

Pepstaiin A and

leupeptin were purchased from Boehringer Mannheim. Cytochrome C and cytochrome
Q6 were purchased from Sigma Chemical Co.. Potassium cyanate was purchased from
EM Science and potassium succinate was purchased from Pfaltz & Bauer Inc..
Radioactive nucleotides, [cx-32P]-dNTP, [y-32P]-ATP and [a-35S]-dATP. were
purchased from Amersham Life Science. Poly(dI-dC)poly(dI-dC) was purchased from
Pharmacia Biotech. The DNA probe for 18S RNA in northern blot analysis and the
primers for PCR amplification of 60 bp and 83 bp DNA fragments were synthesized by
the Gene Laboratory o f Louisiana State University School o f Veterinary Medicine.
Dye reagent for protein assay was supplied by Bio-Rad. Wizard™ miniprep or
midiprep DNA purification system for plasmid DNA purification and PolyATract
mRNA Isolation System were purchased from Promega Chemical Co.. GeneAmp PCR
Reagent was purchased from Perkin Elmer Cetus Co. and Sequenase Version 2.0 DNA
Sequencing Kit was purchased from United States Biochemical Corporation. Ambion
DecaPrime Kit for random labeling of DNA fragment was purchased from Ambion Inc..
Magnetic Dynabeads for purification of DNA binding proteins were purchased from
Dynal Inc.. Qiaquick Gel Extraction Kit was purchased from QIAGEN and the kit of
5'-DNA Terminus Labeling System was purchased from BRL.
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BuGR2 monoclonal antibody against mouse glucocorticoid receptor was
purchased from Affinity BioReagents Co.. Antibody against HNF3a was supplied by
Dr. James Darnell's laboratory (Lei et al., 1991).
Restriction endonucleases, Klenow Fragment o f DNA polymerase 1, Vent DNA
polymerase, T4 DNA ligase and calf intestine alkaline phosphotase were purchased from
New England Biolabs Inc., G1BCO-BRL and Boehringeer Mannheim.
Additional chemicals were obtained from standard suppliers.

Bacterial Strains, Plasmids and Media
The bacterial strains and plasmids used in this study are listed in Table 4. The
plasmid pTATCAT 3.0 was supplied by Gunther Schutz. The plasmid pGEM-T was
purchased from Promega. The plasmid pFKHa was supplied by Dr. James Darnell's
laboratory (Kaestner et al., 1993).
E.coli JM 109 is a deletion mutant which lacks the promoter region and the 5'-end
o f the gene coding the B-galactosidase (LacZ). The plasmid vectors used in this study
carry a short segment of E.coli DNA that contains the regulatory sequences and the
coding sequences for the first 146 amino acids of the lacZ gene. The protein subunits
encoded by bacterial host and plasmid genes can associate to form an enzymatically
active protein. JM109 competent cells for plasmid transformation are made using the
method o f Cohen et al. (1972) or purchased from Boehringer Mannheim. The E.coli
JM I09 was grown in Luria-Bertani liquid medium (Sambrook et al.,
supplemented with 0.1

1989)

mg/ml ampicillin which permits the selection of the

antibiotic-resistant bacteria carrying plasmid DNA; or the cells were grown in a LB-agar

Table 4.

Bacterial Strains and Plasmids Used in This Study.

Strain or plasmid
Ecoli
JM109

Plasmids
pUC19
pTATCAT 3.0
pTAT1.7
pTAT1.2
pGEM-T
pGEM-T-60
pFKHct

Characteristics

Source

recA 1 supE44 endA 1 hsdR] 7 gyrA% relA 1 thiD(lac-proAB)
F[fra£>36 proAB+ tact' lacZDM 15]

Our Lab

A cloning vector
pUC18/CAT recombinant plasmid containing TAT gene from nucleotide *2950 to +62
pUC19 plasmid containing TAT gene from nucleotide -2562 to -800
pUC19 plasmid containing TAT gene from nucleotide -800 to +62
A cloning vector derived from pGEM-5Zf(+) vector for cloning of PCR product
pGEM-t vector containing 60 bp upstream region (from -2463 to -2403) o f TAT gene
pBluescript containing 340 bp PCR product of mouse cDNA for HNF3a fork head domain

Our Lab
Schutz’s Lab
This study
This study
Promega
This study
Damelfs Lab
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plate (Sambrook et al., 1989) supplemented with 0.1 mg/ml ampicillin, 200 mg/ml IPTG
and 20 mg/ml X-gal, which permits the selection o f antibiotic-resistant bacteria carrying
plasmid with an insert o f a foreign DNA fragment.

Preparation of Nuclear Extracts
Nuclear protein extracts were prepared from lean and obese animals by the
method of Bernal et al. (1978). Liver tissues were taken from 4 to 12 week old lean and
obese Zucker rats. For each preparation, 7.5 g of liver tissue was minced in solution
SMDP (0.32 M sucrose, 1 mM MgCI2, 1 mM DTT, 1 mM PMSF, 1 mM pepstatin A,
1 mM leupeptin) and the supernatant was aspirated. The pellet o f minced liver tissue
was resuspended in 15 ml of SMDP, homogenized and centrifuged at l,t00xg for
10 min. The pellet was mixed with 30 ml SMDP and centrifuged at I , lOOxg for 10 min.
The pellet was then mixed with 30 ml of solution HSP (2.4 M sucrose, ImM PMSF,
I mM DTT) and the suspension was centrifuged in a Beckman fixed angle Ti 50.2 rotor
at 130,000xg for 45 min.

The pellet was resuspended in 9 ml of solution SMTDP

(0.32 M sucrose, I mM MgCl2, 1 mM DTT, 1 mM PMSF) to which 250 ml o f 10%
Triton X was added. After incubation at 4°C for 5 min, the suspension was centrifuged
at 1.400xg for 10 min. The pellet was washed with 10 ml of SMTDP and sedimented by
centrifugation at 1.400xg for 10 min. This pellet contained purified nuclei. The purified
nuclei were mixed with 3.75 ml of solution KMTDP (0.4 M KC1, 1 mM MgCI2, 10 mM
Tris-HCl pH8.0, 1 mM DTT, 1 mM PMSF), incubated for I hour (Vortex with magnetic
bar 4 times per hour), centrifuged in Beckman Ti 50.2 at 150,000xg for 1 hour. The
supernatant was used as nuclear protein extract.
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Evaluation of the Purity of the Nuclear Extracts
The purified nuclei were checked under light microscope.

The purity of the

nuclear extract was evaluated by means of testing the presence o f the activity o f
succinate-cytochrome c reductase, a mitochondrion marker, in nuclear extracts.

Six

preparations of nuclear extracts were tested. Each reaction was set up in a volume of
1.2 ml buffer containing 10 mM potassium phosphate, 10 mM Tris-HCl, 1 mg
cytochrome C, 0.06 pM cytochrome Q6, 200 pg nuclear extract proteins, and incubated
in a cuvette at 30°C for 10 minutes, then 12 pi of 0.1 M potassium cyanate was added to
a final concentration of 1 mM and 12 pi of 1 M potassium succinate (pH7.4) to a final
concentration of 10 mM. The reactions were monitored at 550 nm for 2 minutes at
10 second-intervals against a control lacking only the nuclear proteins. The specific
activity was calculated as follows:

A O. D./minute / mg protein

= Micromoles cytochrome C reduced/minute/mg protein

Determination of Protein Concentration of Nuclear Extract
Protein concentration of the nuclear extract was assayed using Bio-Rad dye
binding method o f Bradford (1976).

Dye reagent was provided as a five-fold

concentrate. The dye was diluted to IX concentration and filtered through Whatman
No.l paper before use.

Bovine serum albumin (BSA) in several dilutions from

0.2 mg/ml to 1 mg/ml was used as a standard. Nuclear extract undiluted as well as in
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dilutions o f 1:2 and 1:4 were prepared. An aliquot of 0.1 ml of standards and samples of
nuclear extract were mixed with 5 ml IX dye reagent, incubated at room temperature for
30 min, and measured at ODw versus a reagent blank. The ODw versus concentration
o f standards was plotted and the content of nuclear proteins was determined based on the
standard curve.

Plasmid Reconstruction
A DNA clone (pTATCAT3.0) containing upstream region of the TAT gene was
kindly supplied by Gunther Schutz.

This clone contains a 2950 bp upstream DNA

fragment of the TAT gene from nucleotide -2950 to +62 in a pUC 18/cat recombinant
plasmid (Fig. I ). For gel retardation assay, DNA fragments smaller than 300 bp arc
required and each of these DNA fragments should have a 3'-recess end which could be
labeled by filling in a radioactive nucleotide with Klenow fragment of DNA
polymerase I. A number of restriction enzymes are needed to generate such small DNA
fragments from entire 2.9 Kb upstream region o f the TAT gene. However, some o f these
restriction enzymes have multiple restriction sites in the -2.9 Kb region of TAT gene and
generate several DNA fragments, some of which have similar size. Purification of these
fragments is very difficult. To avoid this, the 2.9 Kb upstream region of TAT gene was
digested into two DNA fragments which were then subcloned into pUC19 plasmid. As
is shown in Fig. 1, a 1,750 bp Xbal and PstI restriction fragment from -2.550 to -800 o f
TAT gene was cloned into pUCI9, and the new plasmid was named pTAT 1.7.
Similarly, a l,200bp PstI and EcoRJ restriction fragment containing a region from -800
to +62 of TAT gene and 220 bp of CAT gene was cloned into pUCI9, and the new

F.coRI

X b .I

pTAT1.7
4300 bpi TATr7

P it I

pTAT1.2
3800 bps

T A T I.2

Pat I

Fig. 1.
Plasmid Reconstruction. The plasmid (pTATCAT3.0) containing the
upstream region o f the TAT gene from -2,950 bp to +62 bp was digested with Xbal/PstI
and Pstl/EcoRI restriction enzymes, resulting in two DNA fragments, 1,750 bp Xbal/PstI
fragment and 1,200 bp Pstl/GcoRl fragment, were cloned into pUC 19 plasmid.
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plasmid was named pTAT 1.2. These two plasmids have served as the source of DNA
fragments for the gel retardation assay.

Amplification and Isolation of Plasmid DNA
The plasmid DNA was transformed into JM109 E.coli bacteria for amplification.
TV |

Isolation o f plasmid DNA was performed using the Wizard

miniprep or midiprep

DNA purification system. Cells containing recombinant plasmid were grown overnight
with shaking in I.-broth containing 100 pg/ml o f ampicillin. The overnight growth of
cells was pelleted by centrifugation and resuspended in cell resuspension solution
(50mM Tris-HCI, pH 7.5, lOmM EDTA, lOOpg/ml RNase A). Cell lysis solution (0.2M
NaOH, 1% SDS) and neutralization solution (I.32M potassium acetate, pH4.8) were in
turn added. Cell debris was removed by centrifugation. The supernatant was mixed with
the purification resin and transferred to a column which was then washed with column
wash solution (80mM NaCl, 8mM Tris-HCI, pH 7.5, 2mM EDTA) and vacuum-dried.
Plasmid DNA was eluted from resin with preheated (65°C) TE buffer.

Generation and Labeling of DNA Fragments
Seven DNA fragments from pTAT 1.7 and three DNA fragments from pTAT 1.2
were generated with different restriction enzymes. These DNA fragments had sizes o f
118 bp to 318 bp and covered the region from -2562 to -1100 and -800 to -52 o f the
upstream region of TAT gene (Fig. 2). All these DNA fragments contained 3'-recess
ends to which [a-32P]-dNTP could be incorporated using the Klenow fragment o f DNA
polymerase 1. These labeled DNA fragments were purified through Bio-Gel-30 spin
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Fig. 2.
DNA Fragments Generated from the Upstream Region of the TAT Gene
with Different Restriction Enzymes. The DNA fragments were generated with multiple
restriction enzymes, labeled with [a-32P]-dNTPs by Klenow fragment o f DNA
polymerase I and used in gel retardation assay. The shaded boxes indicate the difference
in the amount o f protein-DNA complex formation between lean and obese rats. The
dotted boxes indicate the slight difference in the amount of protein-DNA complex
formation between lean and obese rats. The blank boxes indicate no difference between
lean and obese rats.
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column. Two additional DNA fragments, an 83bp fragment from -2531 to -2449 and a
60bp fragment from -2463 to -2403, were generated by PCR using 20 base primer pairs
which were synthesized by the Gene Laboratory of Louisiana State University School of
Veterinary Medicine (Fig. 3).

GeneAmp PCR Reagent and Vent DNA polymerase

rather than AmpliTaq DNA polymerase were used for primer extension.

The PCR

reactions were performed in the presence of [a-J2P]-dATP for labeling.

After

amplification, the DNA fragments were purified through polyacrylamide gels and eluted
from the gel slices using SixPac Gel Eluter (Hoeffer Scientific, San Francisco, CA).
These purified DNA fragments were used as probes in gel retardation assays.

DNA Cloning
The 60 bp DNA fragment from PCR was ligated into a pGEM-T vector by T4
DNA ligase.

The resulting plasmid which includes 60 bp insert was named

pGEM-T-60. The ligation was performed in 10 pi buffer containing 50 ng pGEM-T
vector, 2 pi PCR product, 1 pi T4 DNA ligase. The reaction was incubated at 16°C for
3 hours, then heated at 70°C for 10 minutes and cooled down to the room temperature.
An aliquot of 2 pi ligation reaction was mixed gently with 50 pi thawed JM I09
competent cells and incubated at 4°C for 20 minutes, then heat-shocked at 42°C for
50 seconds and chilled on ice for 2 min. The transformation reaction was mixed with
I ml o f L-broth and incubated at 37°C with shaking (200rpm/min) for I hour.

An

aliquot of 50 pi o f cell suspension was spread onto a LB/Amp/IPTG/Xgal plate
(ampicillin 0.1 mg/ml, IPTG 200 mg/ml, X-gal 20 mg/ml) to select transformants.
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Fig. 3.
Amplification of DNA Fragments Using PCR Technique. The 192 bp
DNA fragment of the TAT Upstream Region was used as template and two small DNA
fragments, an 83 bp fragment and a 60 bp fragment, were generated and labeled with
[a- 2P]-dATP by PCR. These two small labeled DNA fragments were used for gel
retardation assay.
The shaded box indicates the difference in the amount of
DNA-protein complex formation between lean and obese rats. The blank box indicates
no difference in amount of DNA-protein complex formation between lean and obese
rats.
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DNA Sequencing
The cloned 60 bp DNA fragment was sequenced using dideoxy-mediated chain
termination sequencing technique (Sanger et al. 1977). All the reagents for sequencing
were supplied by Sequenase version 2.0 DNA sequencing kit. Double stranded template
DNA was denatured by mixing 5 pi (I pg/pi) pGEM-T-60 DNA with 0.5 pi of alkaline
solution containing 2 M NaOH and 2 mM EDTA. The reaction was incubated at 37°C
for 30 minutes. The denatured DNA was ethanol precipitated and resuspended in 7 pi
H20 . Annealing reaction was performed by mixing 7 pi denatured DNA template with
2 pi o f 5X buffer and 1 pi "universal'* primer, and incubating at 65HC for 2 minutes, then
cooling down to the room temperature. Labeling reaction was performed by mixing
10 pi annealed DNA mixture with 1 pi DTT (0.1 M), 2 pi diluted labeling mixture
(1:5 dilution), 0.5 pi [a-35S]-dATP and 2 pi diluted sequenase polymerase (1:8 dilution),
incubating at room temperature for 5 minutes.

At the same time. 2.5 pi of each

termination mix (G,A,T,C) was placed in 1.5 ml tube and pre-warmed in 37°C water
bath.

Termination was achieved by adding 3.5 pi of labeling reaction to each

termination tube and incubating at 37°C for 5 minutes. The reactions were then stopped
by adding 4 pi stop solution to each tube. All reactions were denatured at 75<1C for
2 min before loading onto 6% denaturing polyacrylamide wedge-shaped sequencing gel
(Bankier et al. 1983; Reed et al. 1986) which was prerun for 60 min. After loading of
the samples, electrophoresis was performed at 30 W for 2 hours. The gel was then
soaked in solution containing 5% acetic acid and 15% methanol for 15 min, and dried at
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80°C for 1 hour.

The dried gel was exposed to X-ray film for 3 days.

The DNA

sequence of this clone was read and compared to the original sequence o f the upstream
region o f the TAT gene.

Gel Retardation Assay
1.

Gel Retardation Reactions
Gel retardation assays (GRA) were performed in 20 pi reaction mixtures

containing 10 mM HEPES buffer (pH 7.9), 70 mM KC1. 5 mM MgCI2, 0.1 mM EDTA.
0.5 mM DTT, 15% glycerol, 0.05% NP-40, 2pg poly(dl-dC)poly(dl-dC), 3pg nuclear
protein and 30,000 cpm [a-32P]-labeled DNA fragments. The reaction was incubated at
room temperature for 20 min. Band-shifting was assessed by electrophoresis through
5% polyacrylamide gels with high ionic strength buffer containing 25 mM Tris-HCI (pH
8.0), 192 mM glycine, 1 mM EDTA at 150 V for 2 hours. Gels were exposed to a
Phosphorimager cassette for overnight.
2.

Demonstration of Binding Speci ficity
Specificity o f protein binding to DNA was demonstrated by adding 30-fold

molar excess o f either unlabeled target DNA fragment or unrelated unlabelled sonicated
E. coli B DNA fragment as competitive DNA fragments in the GRA reactions. The
strategy o f demonstrating the specific DNA-protein interaction is illustrated in Fig. 4.
As was shown, the cold target DNA fragment wasable to compete with [a -12P]-labelcd
DNA fragment for binding with nuclear proteins, resulting in a cold DNA-protein
complex which was shifted in gel retardation assay but could not be detected in

▼

3JP labeled target DNA

Unlabelled, unrelated Ecoli DNA

Unlabelled target DNA

Specific DNA binding protein

Direction of electrophoresis

Fig. 4.

Strategy of Gel Retardation Assay
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autoradiography. Whereas, the unrelated E coli DNA fragment was not able to compete
with (a -,2P]-labeled DNA fragment, therefore the gel retardation pattern would remain
unaltered.
3.

Antibody Interference
The role o f glucocorticoid receptor in the formation of the DNA-protein complex

was studied by preincubation of nuclear proteins with a serial dilution (1:100 to 1:3200)
o f BuGR2 monoclonal antibody against mouse glucocorticoid receptor (Gametchu and
Harrison, 1984) at 4°C for 1 hour prior to incubation with [a-32P]-labeled target DNA.
The role of hepatic nuclear factor (HNF3a) in the formation of DNA-protein
complex was also studied.

The anti-HNF3a antibody was supplied by Dr. James

Darnell's laboratory (Lai, et al., 1991). The nuclear protein was preincubated with the
antibody at 4°C for 15 min prior to incubation with [a-32P]-labeled target DNA.
Alternatively, the nuclear protein was incubated with [a-12P]-labeled target DNA for
20 min at room temperature, then the antibody was added and incubated successively at
room temperature for 15 min.
4.

Phosphorylation Interference
The role of phosphorylation in the DNA-protein complex formation has been

investigated.

The nuclear proteins from lean or obese rats were preincubated with

increasing amounts (0.08U to 8U) of calf intestine alkaline phosphatase at 30°C for
30 minutes. The (a-32P]-labeled 60 bp DNA fragment was then added and the reaction
was incubated successively at room temperature for 20 minutes.
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Purification of DNA Binding Proteins
Two methods were used to purify the proteins from DNA-protein complexes.
1.

Electrophoretic Elution
The shifted hand containing DNA-protein complex was excised from the gel.

The proteins were electro-eluted from the excised gel slice using SixPac Gel Eluter
(Hoeflfer Scientific, San Francisco, CA) at 50 V for two hours in Tris-glycine-SDS
buffer. The eluted proteins were concentrated and desalted in Microcon-10.
2.

DNA Affinity Dynabeads Purification
In this approach the DNA-binding proteins were purified using magnetic DNA

affinity beads by the method of Gabrielsen and Huett ( 1993). Fig. 5 shows a scheme of
protein purification strategy.
The 60 bp DNA fragment from -2463 to -2403 of the TAT gene was generated
by PCR using 20 base primer pairs. One of these primers was biotin-labeled at the
5'-end so that the PCR amplified 60 bp DNA fragments could covalently bind to the
streptavadin which was linked to the surface o f the Dynabeads.
The M-280 Dynabeads (5mg) were washed once in phosphate buffered saline
containing 0.1% bovine serum albumin (fraction V) and three times in TEN buffer
(lOmM Tris-HCI, ImM EDTA and lOOmM N aC t) before addition of 8pg of 60 bp
Biotin-labeled DNA fragments.

After incubation at room temperature with gentle

agitation for 30 minutes, the DNA-coupled Dynabeads were magnetically sedimented
and washed 3 times in TEN buffer.

A set of three reactions was performed for

purification of lean or obese nuclear protein.

In each reaction, the DNA-coupled

Fig. 5.
The Scheme of Protein Purification Using Magnetic DNA Affinity
Dynabeads. The biotin labeled 60bp DNA fragments covalently bind to the streptavadin
which is linked to the surface of the Dynabeads. A: the crude nuclear extract. B: The
DNA coupled Dynabeads are incubated with crude nuclear extract.
C: The
DNA-binding-proteins are separated from non-DNA-binding-proteins by magnet.
D: The unrelated DNA fragments was added. E: The unrelated DNA fragments act as
competitors to remove non-specific DNA-binding-proteins. F: The specific DNA
binding proteins are finally eluted from the DNA coupled Dynabeads.
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magnetic Dynabeads (Im g) were incubated with ISO pg nuclear protein in 200 pi o f
HEDGN-200 buffer (lOmM HEPES. ImM EDTA, O.SmM DTI , 15% glycerol, 0.05%
NP-40, 200mM KCI) at room temperature for 10 min before magnetically separation of
the beads from the supernatant. The following three steps o f wash-incubation-wash were
performed in reaction I and 2 but were not performed in reaction 3. The protein-bound
DNA affinity Dynabeads in reaction 1 and reaction 2 were washed once with 0.5 ml
HEDGN-200 buffer, and the protein-bound DNA affinity Dynabeads in reaction I were
incubated for 5 minutes in 0.2 ml of HEDGN-200 including 16 pg poly dl-dC or
alternatively the protein-bound DNA affinity Dynabeads in reaction 2 were incubated for
5 minutes in 0.2 ml of HEDGN-200 including 16 pg poly dl-dC as welt as 0.5mg/ml
bovine serum albumin.

The beads were then magnetically separated from the

supernatant and washed again with 0.5 ml HEDGN-200 buffer. Proteins were eluted in
20 pi HEDGN buffer containing I M KCI. As a control in reaction 3, proteins were
eluted from the protein-DNA-Dynabeads complex directly after incubation of protein
with DNA-coupled Dynabeads without successive three steps of wash-incubation-wash
between steps of protein binding and protein elution.

Analysis of purified proteins
I.

SDS-PAGE denaturing gel electrophoresis
The proteins purified using these two methods were analyzed by 8% or 10%

SDS-PAGE (l.aemmili, 1970) gel at 20mA for 4.5 hours. After electrophoresis, the gel
was then silver-stained using Bio-Rad silver staining kit.
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2.

Gel retardation assay
The proteins obtained from DNA-affinity Dynabeads purification were used in

gel retardation assay. An aliquot of 4 pi o f protein eluate from each purification was
used in get retardation reaction. The content of the purified protein was not quantitated.

Northern Blot Analysis of HNF3a tnRNA
1.

Total RNA and mRNA preparation
Two lean and two obese rats were used for this experiment. Liver tissues o f lean

and obese rats were rapidly removed, washed briefly in sterile saline and frozen in liquid
nitrogen.

Total RNA was extracted from liver tissue of lean and obese rats by the

guanidinium thiocyanate-phenol-chloroform method described by Chromczynski and
Sacchi (1987). One gram liver samples from each rat wasprocessed separately,
tissue was quickly ground in liquid nitrogen andhomogenized

frozen

inguanidinium

thiocyanate denaturing solution using a polytron tissue homogenizer (Brinkman
Instruments, Westbury, NY).

RNA was extracted with water-saturated phenol and

chloroform. The aqueous phase was separated from organic phase by centrifugation at
10,000xg for 20 min and transferred to a clean tube to which equal volume of
isopropanol was added. The RNA was precipitated and pelleted by centrifugation at
I0,000xg for 20 min. The RNA pellet was then dissolved in RNase-free water and RNA
content was determined by spectrophotometry (A260).
Messenger RNA was purified from total RNA using PolyATract mRNA
Isolation System. An aliquot o f 800 pg of total RNA of each sample was denatured and
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annealed with Biotinylated-Oligo (dT) probe. Meanwhile, Streptavidin-Paramaganetic
Particles (SA-PMPs) were washed three times with 0.5X SSC. The annealing reaction
was then incubated with washed SA-PMPs in 0.5X SSC at room temperature for 10 min.
The SA-PMPs were captured using a Magnetic Stand and washed four times with O.IX
SSC. Messenger RNA was finally eluted in RNase-free water and the mRNA content
was determined by spectrophotometry (A260).
2.

Gel Electrophoresis and Membrane Transfer of mRNA
An aliquot of 5pl (lpg/pl) mRNA o f each sample was mixed with 20pl RNA

Loading Buffer (5 prime®— prime. Inc.) and denatured at 55°C for 15 min.
denatured

mRNA

sample

was

then

separated

by

electrophoresis

in

The
1%

agarose-formaldehyde gel in IX MOPS buffer (3-N-Morpholinopropane-sulfonic acid)
at 70V for 5 hours and transferred onto nylon membrane (HybondIM-N, Amersham
International, NY) in I OX SSC (1.5M NaCl, 0 .15M trisodium citrate) for overnight. The
transferred membrane was baked for 2 hours at 80°C to immobilize the mRNA.
3.

Probe Preparation
A clone of pFKHa containing 340 bp PCR product of mouse cDNA for HNF3a

fork head domain (Fig. 6) was supplied by Dr. James Darnell's Laboratory (Kaester ct
al., 1993). The sequence of this cDNA clone is homologous to the cDNA sequence of
HNF3 genes including genes of HNF3a, B and y. (Lai, 1991). The pFKHa plasmid
DNA was double digested with restriction enzyme Asp718 and BamHI to generate
340 bp DNA fragment. This fragment was purified through agarose gel, and recovered

Bam HI

Spel
Xbal
Notl i
SacII.
SacI . H i
AspTlfi
340bp

BubHI

A*p718

pFKH(
3300 bps

340bP

Fig. 6.
Map of pFKHa. The pFKHa plasmid containing 340 bp PCR product of mouse cDNA for HNF3a
domain was digested with restriction enzymes of BamHl and Asp718. The BamHl/Asp718 DNA fragment was used as
template in random labeling reaction to generate probe for northern blot analysis of HNF3a mRNA.
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from the gel slice using Qiaquick Gel Extraction Kit. The purified 340bp DNA fragment
was used as template in random labeling reaction.
The DNA probe for detecting HNF3 mRNA was random labeled using an
Ambion DecaPrime Kit.

The template DNA (50 ng) was denatured and annealed

randomly with DecaMers. The probe was then synthesized using the Klenow Fragment
o f DNA polymerase I in the presence o f [ct-32PJ-dATP. The synthesized probe was
purified using Bio-Gel-30 spin column.
The oligonucleotide probe for 18S RNA was synthesized by the Gene
Laboratory of Louisiana State University School of Veterinary Medicine. The probe
was labeled with [y-32P]-ATP at 5*-end by T4 kinase using 5'-DNA Terminus Labeling
System. Afier labeling the probe was purified using Bio-Gel-30 spin column.
4.

Hybridization
Baked membrane was prehybridized at 42°C for 5 hours in 20 ml solution

containing 50% deionized form amide, 5X SSPE, 5X Denhardt's solution, 0.5% (w/v)
SDS, and 0.5 mg denatured Calf Thymus DNA. After prehybridization, [a-32P]-labeled
probe (6xl07 cpm) for HNF3 mRNA was added. Hybridization was performed at 42°C
for overnight. Membranes were washed at room temperature in 2X SSPE, 0.1% SDS
twice for 10 min each. The radioactive membranes were exposed to phosphor screen
(Molecular Dynamics Inc., Sunnyvale, CA). The probe for HNF3 was stripped from the
membrane by dipping in boiled solution of 0.1% SDS. The same membrane was reused
for probing 18S RNA. The conditions for prehybridization and hybridization for 18S
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RNA were as the same as that for HNF3 mRNA except that the oligonucleotide probe
(9.8x105 cpm) for 18S RNA was added. Radioactive membrane was also exposed to
phosphor screen. Signals were quantified as ratio of HNF3 mRNA to 18S RNA using
ImageQuant software.

RESULTS
Purity of Nuclear Extract
There are two main sources of DNA binding proteins in animal cells,
mitochondria and nuclei.

To eliminate contamination of nuclear extract by

mitochondrial proteins, the activity of succinate-cytochrome C reductase, a mitochondria
marker, was tested. Table S shows that the activity of succinate-cytochrome c in nuclear
extract was almost zero, indicating the purity of the nuclear extract.

Comparison of Nuclear Extracts of Lean and Obese Rats by Band Shift Assay
DNA fragments from upstream region of TAT gene and hepatic nuclear extract
from lean and obese Zucker rats were used in gel retardation assay. In initial studies, ten
DNA fragments o f the upstream region of TAT gene were investigated. O f these ten
DNA fragments, six are shown to differ in the amount of DNA fragment shifted by
nuclear proteins from lean and obese rats in gel retardation assay (Fig. 7, 8, 9); two are
shown to be slightly different (Fig. 10) and the other two showed no differences between
lean and obese rats (Fig. II). In each case that showed differences in gel retardation
assay between lean and obese rats, increased amounts of DNA fragment was shifted by
the nuclear extract from obese rats in comparison to the nuclear extract from lean rats.
The region between -2562 to -2370 bp was selected for more thorough examination,
because that 192 bp DNA fragment showed the largest difference between lean and
obese rats (Fig. 7). The 192 bp DNA fragment contains two GRE sites which have been
defined as GRE II and GRE III (Jantsen et al, 1987) (Fig. 3). Two DNA fragments, one
83 bp (-2532 to -2450) and the other 60 bp (-2463 to -2402), were generated and labeled
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Table 5.

The Specific Activity of Succinale-Cytochrome C Reductase in Nuclear Extract

Sample

Animal

Nuclear

Protein

A O.D./min

Specific

Genotype

Sex

Number

Extract

(mg)

1

-

-

-

-

-

0.0000

0.0000

2

fa/fa

M

2

pooled

0.2

0.0023

0.0006

3

fa/+

M

2

pooled

0.2

0.0019

0.0005

4

+/+

M

1

non-pooled

0.2

0.0023

0.0006

5

fa/fa

M/F

2/1

pooled

0.2

0.0010

0.0003

6

fa/+

M/F

2/1

pooled

0.2

0.0013

0.0004

7

+/+

M/F

2/1

pooled

0.2

0.0000

0.0000

No.

Activity

MC*

0.406

The specific activity was calculated as follows:
A O D/minute / mg protein
---------------------- — ------J8.5

=

^
.
Micromoles cytochrome C reduced/minute/mg protein

MC*: Mitochondria. Reference from Taylor, et al.. 1994
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Fig. 7.
Gel Retardation Assay Using 192 bp and 200 bp DNA Fragment of the TAT Upstream Region. The
192 bp DNA fragment from -2370 to -2562 (A) and the 200 bp DNA fragment from -1102 to -1302 (B) of TAT
upstream region were used as target DNA. The reaction includes 3 pg nuclear protein from lean or obese rats and
30,000 cpm [a-32P]-labeled DNA fragment. In lane 3 and 7 include 6 pg nuclear protein either from lean or obese
rats. +: presence. •: absence. O: nuclear extract from obese rats. L: nuclear extract from lean rats. The cold target
DNA and unrelated unlabeled DNA were added in a 30-fold molar excess to demonstrate the specificity of
DNA-protein interaction.
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Fig. 8.
Gel Retardation Assay Using 233 bp and 234 bp DNA Fragment of the TAT Upstream Region. The
233 bp DNA fragment from -1740 to -1973 (A) and the 234 bp DNA fragment from -1506 to -1740 (B) of TAT
upstream region were used as target DNA. The reaction includes 3 pg nuclear protein from lean or obese rats and
30,000 cpm [a-32P]-labeled DNA fragment Lane 3 and 7 in panel A include 6 pg nuclear protein either from lean
or obese rats. +: presence -: absence. O: nuclear extract from obese rats. L: nuclear extract from lean rats. The
cold target DNA and unrelated unlabeled DNA were added in a 30-fold molar excess to demonstrate the specificity
of DNA-protein interaction.

1 2
“ P-Labekd DNA:
Nuclear Extract:
Cold Target DNA:
Unrelated DNA:

3

+ + +
- L L
* - - -

4

5

6

7

8

9

+ + + + + +
L L O O O O

+ - - - +
- + * - - +
-

B.
“ P-Labeled DNA:
Nuclear Extract:
Cold Target DNA:
Unrelated DNA:

1 2 3 4 5 6 7 8 9 10
+ + + + + + + + + +
- L L L L L O O O 0
+

11

+
0
+

Fig.9.
Gel Retardation Assay Using 314 bp and 318 bp DMA Fragment of the TAT Upstream Region. The 314
bp DNA fragment from -486 to -800 (A) and 318 bp DNA fragment from -52 to -369 (B) o f TAT upstream region were
used as target DNA. The reaction includes 3 pg nuclear protein from lean or obese rats and 30,000 cpm [a-32P]-labeled
DNA fragment. Lane 3 and 7 in panel A include 6 pg nuclear proteins. Lane 3 and 8 in panel B include 4 pg nuclear
proteins. Lane 4 and 9 in panel B include 6 pg nuclear proteins. +: presence.
absence. O: nuclear extract from
obese rats. L: nuclear extract from lean rats. The cold target DNA and unrelated unlabeled DNA were added in a
30-fold molar excess to demonstrate the specificity of DNA-protein interaction.
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Fig. 10.
Gel Retardation Assay Using 246 bp and 118 bp DNA Fragment of the TAT Upstream Region. The
246 bp DNA fragment from -1973 to -2219 (A) and the 118 bp DNA fragment from -369 to -486 (B) of TAT
upstream region were used as target DNA. The reaction includes 3 pg nuclear protein from lean or obese rats and
30,000 cpm [a-32P]-labeled DNA fragment. Lane 3 and 7 in panel A and B include 6 pg nuclear proteins either
from lean or obese rats. +: presence.
absence. O. nuclear extract from obese rats. L: nuclear extract from lean
rats. The cold target DNA and unrelated unlabeled DNA were added in a 30-fold molar excess to demonstrate the
specificity of DNA-protein interaction.
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Fig, 11,
Gel Retardation Assay Using 151 bp and 204 bp DNA Fragment of the TAT Upstream Region. The 151
bp from -2219 to -2370 (A) and 204 bp DNA fragment from -1302 to -1506 (B) o f TAT upstream region were used as
target DNA. The reaction includes 3 pg nuclear protein from lean or obese rats and 30,000 cpm [a- 2P]-labeled DNA
fragment. Lane 3 and 5 in panel A include 6 pg nuclear protein either from lean or obese rats. +: presence.
absence.
O: nuclear extract from obese rats. L: nuclear extract from lean rats. The cold target DNA and unrelated unlabeled
DNA were added in a 30-fold molar excess to demonstrate the specificity of DNA-protein interaction.
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using PCR technique. Each of these DNA fragments contains a GRE site with the GRE
II in the 83 bp fragment and GRE III in the 60 bp fragment (Fig. 3). Results of a band
shift study using the 60 bp DNA fragment shows that there are three DNA-Protein
complexes formed. Usage of competitive DNA fragments demonstrated that complexes
I and II are specific DNA-protein complexes while complex III was a non-specific
complex. O f these two specific DNA-protein complexes, only complex I was found to
be present in larger quantity when the nuclear extract from obese rats was used in
comparison to that from lean rats (Fig. 12). Complex II includes two shifted DNA bands
which sometimes can not be separated well. There is almost no difference in band shift
pattern between lean and obese rats when 83 bp DNA fragment was used in band shift
studies (Fig. 13). Four replicates of this experiment using nuclear proteins from four
preparations o f lean and obese nuclear extracts have shown similar results.

Comparison of 75 bp DNA Fragment with 60 bp DNA Fragment
The 60 bp DNA fragment from PCR was cloned into pGEM-T vector.

The

recovered SacII and Spel restriction fragment was about 75 bp with additional bases at
both sides o f the 60 bp DNA fragment (Fig. 14). This DNA fragment was labeled with
[a-32P]-dCTP at 3'-recess end by KJenow fragment of DNA polymerase I and used in gel
retardation assay.

However this 75 bp DNA fragment did not show the same gel

retardation pattern as the 60 bp fragment. DNA sequencing information showed that this
cloned 60 bp fragment had exactly the same sequence as the original one, suggesting that
additional bases which were from plasmid DNA and accounted for about 25% o f the
bases o f cloned 60 bp DNA fragment might have inhibited binding of nuclear protein.
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Fig. 12.
Gel Retardation Assay Using 60 bp DNA Fragment of the TAT
Upstream Region. The DNA fragment from -2461 to -2402 of TAT upstream region
was used as target DNA. The reaction includes 3 pg nuclear protein from lean or obese
rats and 30,000 cpm la -32P]-labeled DNA fragment. +: presence.
absence.
O: nuclear extract from obese rats. L: nuclear extract from lean rats. The specific
binding o f protein to the DNA fragment was demonstrated by adding a 30-fold molar
excess o f unlabeled target DNA fragment or unlabeled, unrelated E.coti DNA fragment.
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Fig. 13.
Gel Retardation Assay Using 83 bp DNA Fragment o f the TAT
Upstream Region. The 83 bp DNA fragment o f TAT upstream region from
-2S32 to -2450 was used as target DNA. The reaction includes 3 pg nuclear
protein from lean or obese rats and 30,000 cpm [a -32P)-labeled DNA fragment.
+: presence.
absence. O: nuclear extract from obese rats. L: nuclear extract
from lean rats. The cold target DNA and unrelated unlabeled DNA were added
in a 30-fold molar excess to demonstrate the specificity o f DNA-protein
interaction.
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75 bp fragment
5-CCGCGGGATT.
3-GGCGCCCTA-
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Fig. 14.
Comparison of 75 bp DNA Fragment with 60 bp DNA Fragment. The 60 bp DNA fragment of
PCR product was ligated with pGEM-T vector. The new plasmid was named as pGEM-T-60 and digested with
Sac II and Spel restriction enzymes. The Sacll/Spel restriction fragment was about 75 bp with additional bases at
both sides of the 60 bp fragment.
'j
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Purification of Proteins from the Protein-DNA Complexes
Electro-elution o f proteins from the 60 bp DNA-protein complexes 1, which
exhibits the difference of protein-DNA interaction between lean and obese rats, resulted
in the identification of three proteins of approximate molecular weights 55, 59 and 62
K.Da (Fig. 15). Proteins purified from the 192 bp DNA-protein complex formed by the
nuclear extracts from lean and obese rats were identical in size (Fig. 16). Since these
proteins were also present when nuclear extracts were electrophoresed in the absence of
DNA fragments it was necessary to utilize a different purification method to verify that
these proteins were part of the DNA-protein complexes rather than proteins which
comigrated with DNA-protein complexes. The biotin-labeled 60 bp DNA fragment was
covalently linked to magnetic DNA affinity beads and these were used to purify specific
DNA binding proteins from hepatic nuclear extracts of lean and obese rats. This method
o f purification resulted in the isolation of the same three proteins (Fig. 17), indicating
that these three proteins are indeed part o f the DNA-protein complex.

The Nuclear Proteins Isolated Using DNA-Affinlty Dynabeads Shifted DNA
Fragment in Gel Retardation Assay
The possibility that the proteins which were isolated using DNA-affinity
Dynabeads would bind to the DNA fragment and reconstitute the DNA-protein
complexes was investigated. The nuclear proteins which were isolated from lean and
obese nuclear extracts using magnetic DNA affinity Dynabeads purification system were
used in the gel retardation assay. The proteins without thorough wash before elution
from DNA affinity beads could form complex 1 and complex II with 60 bp labeled DNA
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Fig. 15.
Analysis of Proteins Purified from 60 bp DNA-Protein
Complexes. The proteins purified from 60 bp DNA-protein complex 1 using
electro-elution were analyzed by electrophoresis in 8% SDS-PAGE at
20 mA for 4.5 hours and stained with silver. Lane 1-2: protein markers.
Lane 3-4: proteins purified from the DNA-protein complexes formed with
nuclear extract o f lean rats.
Lane 5-6: proteins purified from the
DNA-protein complexes formed with nuclear extract o f obese rats.

Fig. 16.
Analysis of Proteins Purified from 192 bp DNA-Protein Complexes. The proteins purified from
192 bp DNA-protein complex were analyzed by electrophoresis in 8% SDS-PAGE at 20 mA for 4.5 hours and stained
with silver. Lane 1: protein markers. Lane2 and 5: Blank. Lane 3 and 4: proteins purified from DNA-protein
complex formed with nuclear extract of lean rats. Lane 6 and 7: proteins purified from DNA-protein complex formed
with nuclear extract of obese rats. Lane 3 and 6: proteins eluted by soaking in SDS-buffer for overnight with shaking.
Lane 4 and 7: proteins purified using electro-elution.

00

to

83

1

2

3

4

5

6

7

8

116.3 KDa->
97.4 KDa->

66.2 KDa-»

62KDa
59KDa
55KDa

43 KDa-*

Fig. 17.
Analysis o f Proteins Obtained from DNA Affinity Dynabeads by
SDS-PAGE Electrophoresis. The proteins obtained from DNA affinity Dynabeads were
analyzed by electrophoresis in 10% SDS-PAGE at 20mA for 4.5 hours and then stained
with silver. Lane 1: protein markers. Lane 2: bovine serum albumin. Lane 3-5: proteins
obtained from nuclear extract of lean rats. Lane 6-8: proteins obtained from nuclear
extract o f obese rats. Lane 3 and 6: proteins isolated with more thorough wash in a
buffer containing 16 pg poly dl-dC before elution from DNA affinity beads. Lane 4 and
7: proteins isolated with more thorough wash in a buffer containing 16 pg poly dl-dC
and 0.5 mg/ml bovine serum albumin before elution from DNA affinity beads. Lane 5
and 8: proteins isolated without thorough wash before elution from DNA affinity beads.
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fragment in gel retardation assay, while the proteins with more thorough wash before
elution from DNA affinity beads could only form complex II (Fig, 18), suggesting that
some protein factor which is necessary for forming of complex I may be lost with the
more thorough wash during protein purification.

Glucocorticoid Receptor Protein Is Not a Part of Specific DNA-Protein Complex
The possibility that the type U glucocorticoid receptor protein was present in the
60 bp DNA-protein complex was investigated by studying the effect of a serial dilution
(1:100 to 1:3200) of monoclonal BuGR2 antibody (500jxg/ml) to the receptor on the gel
retardation assay. The result showed that the antibody had no effect on the band-shift
pattern (Fig. 19). This result in combination with the fact that three proteins which were
purified from the DNA-protein complexes had smaller molecular weight than that of
glucocorticoid receptor protein (97 KDa) and that the 83 bp fragment which had a GRE
binding site showed no difference between lean and obese rats in gel retardation assay
suggests that the glucocorticoid receptor protein is not necessary for the formation o f the
complex that exhibits the band-shift difference between lean and obese rats.

Adrenalectomy Reduced the Specific DNA-Protein Complex Formation
The effect o f adrenalectomy on the formation of specific DNA-protein
complexes was investigated by gel retardation assay using 60 bp DNA fragment and
nuclear proteins from adrenalectomized lean and obese rats. Results showed that the
formation of specific DNA-protein complexes 1 and II were reduced using nuclear
proteins from both adrenalectomized lean and obese rats in comparison with that using
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Complex II
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Complex III—►

Fig. 18.
Gel Retardation Assay Using Nuclear Proteins Obtained from DNA
Affinity Dynabeads. Lane 1: free DNA probe without nuclear extract. Lane 2: crude
nuclear extract from lean rats. Lane 3-5: nuclear proteins of lean rats isolated from
Dynabeads. Lane 6: free DNA probe without nuclear extract. Lane 7: crude nuclear
extract from obese rats. Lane 8-10: nuclear protein of obese rats isolated from
Dynabeads. Lane 3 and 8: proteins isolated with more thorough wash in a buffer
containing 16 pg poly dl-dC before eluted from DNA affinity beads. Lane 4 and
9: proteins isolated with more thorough wash in a buffer containing 16 pg poly dl-dC
and 0.5 mg/ml bovine serum albumin before eluted from DNA affinity beads. Lane 5
and 10: proteins isolated without thorough wash before elution from DNA affinity beads.
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Fig. 19.
The Effect of Anti-Glucocorticoid Receptor Antibody on Gel Retardation
Pattern with 60 bp DNA Fragment of the TAT Upstream Region. The nuclear proteins
were pre-incubated with a serial dilution (1:100 to 1:3200) of BuGR2 monoclonal
antibody against glucocorticoid receptor for one hour prior to incubation with the
[a-32P]-labeled target DNA. Ab: anti-glucocorticoid receptor antibody. NE: nuclear
extract. O: nuclear extract from obese rats. L: nuclear extract from lean rats.
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nuclear proteins from sham-operated control rats, whereas the amount of the specific
DNA-protein complexes formation using nuclear proteins from dexamethasone
replacement treated rats was increased to a level comparable to that using nuclear
proteins from control rats (Fig. 20).

This result indicates that glucocorticoids may

directly or indirectly regulate the level or affinity of the nuclear proteins involved in the
formation of specific DNA-protein complexes.

In addition, there was an additional

DNA-protein complex formation using nuclear extract from adrenalectomized rats. In
contrast to the specific DNA-protein complex I, this complex was present in the larger
quantity when nuclear extract from adrenalectomized lean rats was used in comparison
with that using nuclear extract from adrenalectomized obese rats.

When the nuclear

extract from the adrenalectomized rats treated with dexamethasone replacement was
used, it reduced to a level comparable to that using nuclear proteins from control rats
(Fig. 20).

Dephosphorylation Increased the Formation of DNA-Proteln Complex I but
Reduced the Formation of DNA-Protcin Complex II
Since many transcription factors are regulated by phosphorylation, the possibility
that phosphorylation of nuclear proteins was involved in the formation o f the specific
DNA-protein complexes was investigated.

Nuclear proteins were dephosphorylated

before being used for gel retardation assay.

Results showed that the amount o f the

DNA-protein complex I gradually increased with increased activity o f calf intestine
alkaline phosphatase in the preincubation reactions of gel retardation assay, while the
amount of the DNA-protein complex II decreased as the activity o f phosphatase
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Fig. 20.
The Effect of Adrenalectomy on Gel Retardation Pattern with 60 bp
DNA Fragment of the TAT Upstream Region. The reaction includes 3 pg nuclear
protein from lean or obese rats and 30,000 cpm [a-32P]-labeled DNA fragment.
+: presence.
absence. O: nuclear extract from obese rats. L: nuclear extract from lean
rats. Sham: sham operation. Adx: adrenalectomy. Adx/Dex: adrenalectomized and then
treated with dexamethasone replacement.
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increased in preincubation reactions of the gel retardation assay (Fig. 21).

This

suggested that phosphorylation regulated the formation of specific DNA-protein
complexes and the formation o f the DNA-protein complex I and II might be correlative.
As was shown in gel retardation assay using nuclear extract from adrenalectomized rats,
there was a small DNA-protein complex formation when nuclear proteins treated with
phosphatase was used in gel retardation assay. This small DNA-protein complex is
present in a larger quantity when the nuclear extract horn lean rats was compared with
that from obese rats and the amount of the DNA-protein complex increased
corresponding to the increase o f the activity of phosphatase in the reaction o f gel
retardation assay. (Fig. 21).

Antibody Against HNF3a Caused a Super-Shift of DNA-Protein Complex in Gel
Retardation Assay
The 60 bp DNA fragment contains a HNF3 binding element which overlaps with
GRE III. The possibility that the HNF3a was part of 60 bp DNA-protein complex was
investigated. The antibody against HNF3a was incubated with nuclear proteins after the
nuclear proteins interacted with DNA fragment.

Results showed that the antibody

caused a super-shift of DNA-protein complex in the gel retardation assay.

It also

reduced the amount of the DNA-protein complex I but increased the amount o f the
DNA-protein complex II. Antibody alone, as a control, did not shift any DNA fragment
in the gel retardation assay (Fig. 22). The same result was shown when the antibody
against HNF3a was incubated with nuclear proteins before the interaction o f nuclear
proteins with DNA fragment. These results suggested that HNF3a was present in the
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Fig. 21.
The Effect o f Alkaline Phosphatase Treatment on Gel Retardation Pattern
with 60 bp DNA Fragment o f the TAT Upstream Region. The nuclear extract was
pre-incubated with alkaline phosphatase for 30 min before (a-32P]-Iabeled DNA
fragment was added. The 60 bp DNA fragment of TAT upstream region from -2461 to
-2402 was used as target DNA. The reaction includes 3 pg nuclear protein from lean or
obese rats and 30,000 cpm [a-32P]-labeled DNA fragment. +: presence.
absence.
L: nuclear extract form lean rats. O: nuclear extract from obese rats.

91

32

P-labeled DNA:
Nuclear Extract:
Antibody:

+
-

+

+

+

+

L

O L

O

Supershift Band —>

Complex I

Complex II-

Complex 111—►

Fig. 22.
The Effect o f Anti-HNF3a Antibody on Gel Retardation Pattern with the
60 bp TAT Upstream Region. The antibody was incubated with nuclear proteins after
the nuclear proteins interact with [a-32P]-labeled DNA. The 60 bp DNA fragment o f
TAT upstream region from -2461 to -2402 was used as target DNA. The reaction
includes 3 pg nuclear proteins from lean or obese rats, 30,000 cpm o f [a-32P]-labeled
DNA fragment and 2 pi anti-HNF3a antibody. +: presence. -: absence. L: nuclear
extract from lean rats. O: nuclear extract from obese rats.
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DNA-protein complex I. The antibody may interact with HNF3a which was in the
DNA-protein complex I, resulting in the formation of a larger DNA-protein complex
which is super-shifted in gel retardation assay. Alternatively, the antibody may prevent
HNF3a from binding to DNA or interacting with other proteins due to steric hindrance.
Both o f these result in a reduction of protein-DNA complex I formation. The increased
amount of protein-DNA complex II possibly results from a partially disrupted complex I
which lose a HNF3a factor due to the interference of anti-HNF3a antibody.

The mRNA Levels of HNF3 Gene in Lean and Obese Rats
Since the HNF3a seems to be a part of the DNA-protein complex I which
exhibits the difference in gel retardation assay between lean and obese rats, the
expression o f HNF3a gene may be different between lean and obese rats. The mRNA
level o f HNF3 gene in both lean and obese rats was investigated by northern blot
analysis using FKHa probe which has sequence homologous to the cDNA sequence of
HNF3 gene. Two animals of each phenotype were used in the experiment. In order to
standardize the quantity of the mRNA to be loaded on the gel, the 18S RNA carried over
into the purified mRNA was used as a standard. The probe for HNF3 mRNA was
stripped from the membrane and the same membrane was then probed for the 18S RNA.
The levels of HNF3 mRNA were expressed as a ratio to the signal for 18S RNA. There
was no significant difference in the level o f HNF3 mRNA between lean and obese rats
(Fig. 23, Fig. 24).
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Fig, 23,
Northern Blot Analysis for HNF3a mRNA. An aliquot of
S Mg mRNA of each sample was separated in 1% agarose/formaldehyde gel
and then transferred onto Hybond-N nylon membrane. The 18S RNA
carried over into the purified mRNA was used as a standard. The same
membrane was used for probing HNF3a mRNA and 18S RNA.
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Fig. 24.
The Comparison of the HNF3 mRNA Levels between
Lean and Obese Rats.

DISCUSSION
The excessive response to glucocorticoids in obese Zucker rats can be seen at
several organization levels. Although some non-genomic effects of glucocorticoids in
the brain have been demonstrated (Chen et al., 1994, 1995), glucocorticoids regulate
gene expression at the transcriptional level.

Evidence of elevated mRNA levels of

several genes, such as TAT, ME and GAPDH genes, in obese Zucker rat and their
exaggerated responses to manipulation o f adrenal status of the obese /a/fa rats led to the
hypothesis that the fa mutation may result directly or indirectly in a change in the level
or activity of a transcription factor that modulates glucocorticoid regulated genes. Gel
retardation assays in this study using DNA fragments o f the TAT upstream region and
nuclear extracts of lean and obese rats showed that the larger amounts of DNA fragments
were shifted with nuclear protein from obese rats than that with nuclear protein from lean
rats, suggesting that an alteration in levels or affinity o f a transcription factor or factors is
present in obese nuclei.
The upstream region of the TAT gene has been well characterized (Szyf et al.,
1990, Grange et al., 1989, Espinas et al., 1994). The GRU at -2.5 Kb of the TAT gene
contains three GRE and multiple binding sites for a variety of transacting factors
(fig. 25). The 192 bp DNA fragment (from -2563 to -2370) which showed the largest
difference between lean and obese rats contains two GRE sites (GRE II and GRE 111).
Two small DNA fragments were generated from this region using PCR technique. Each
of them contains one GRE. The 60 bp DNA fragment which contains GRE III showed a
difference in protein-DNA complex formation in gel retardation assay between lean and
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obese rats, whereas the 83 bp DNA fragment which contains GRE II did not show a
difference. In addition, the 97 KDa glucocorticoid receptor (Vedeckis, 1985) was not
one o f the three proteins that was purified by the DNA affinity chromatography.
Antibody interference experiments using the BuGR2 monoclonal antibody did not alter
the gel retardation pattern. All the evidence suggests that nuclear proteins other than the
glucocorticoid receptor protein are responsible for the formation of the DNA-protein
complex which exhibits a difference between lean and obese rats. Although the inability
to alter the gel retardation pattern with the BuGR2 monoclonal antibody might have
been explained by poor interaction of the antibody with the native rather than the
denatured glucocorticoid receptor, the inability to detect protein of appropriate molecular
weight after silver staining of the proteins purified from DNA-protein complex and the
evidence that 83 bp DNA fragment containing a GRE site does not show a difference in
gel retardation assay between lean and obese rats also argues against involvement o f the
glucocorticoid receptor protein in the complex responsible for the gel retardation pattern.
The fact that the glucocorticoid receptor may not be a part of 60 bp DNA-protein
complex is also supported by the studies from other laboratories. Jentzen et al ( 1987)
demonstrated by analysis of deletion mutants that GRE III alone did not convey
glucocorticoid inducibility, while GRE II by itself had one third of maximal activity o f
glucocorticoid induced gene expression using both GRE II and GRE HI.

Since the

palindromic sequence of the GRE 111 is not well conserved, it is possible that binding of
GR to the GRE HI site requires the presence of an adjacent GRE II site.

In vivo

footprinting studies revealed that an element which overlapped with GRE III was bound
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by HNF3 within 10 min o f dexamethasone administration (Rigard et al., 1991, Nitsch et
al., 1993). It has thus been suggested that glucocorticoid receptor might interact with
GRE III site shortly after glucocorticoid induction, change the local chromatin structure,
and then leave the site accessible to HNF3 (Rigard et al., 1991). It is possible that the
synergistic function o f glucocorticoid inducible gene expression may result from the
interaction between HNF3 protein and glucocorticoid receptor rather than two
glucocorticoid receptors in the -2.5 Kb GRU region of TAT gene.

Since a HNF3

binding site overlaps with GRE III of 60 bp fragment (Rigaud et al., 1991, Nitsch et al..
1993), the lack of glucocorticoid receptor in the DNA-protein complex may result from
steric hindrance.

Antibody against HNF3a caused a super-shift of DNA-protein

complex in gel retardation assay, suggesting that the HNF3o is a part o f 60 bp
DNA-protein complex.
Three proteins were purified from the 60 bp DNA-protein complex.

It is

possible that all three proteins are DNA binding proteins. Alternatively, only one o f
these proteins may bind to DNA and the other two proteins are involved in DNA-protein
complex formation by protein-protein interaction.

There are several possibilities to

explain the increased binding of nuclear proteins of obese rats to the 60 bp DNA
fragment when compared with nuclear proteins of lean rats. First, if all three proteins are
DNA binding proteins, it is possible that all three proteins are present at higher levels in
the nuclei of obese rats. Alternatively, the levels of the proteins are the same in nuclei of
both lean and obese rats but the affinity o f these three proteins to the DNA is increased
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in obese rats. It is likely that only one of these proteins has increased binding affinity to
the DNA. Binding of this protein to the DNA facilitates the other two proteins binding
to the adjacent site of the DNA. Second, if only a single protein interacts with DNA and
this protein is present in excess, or has a higher binding affinity in nuclei of obese rats, it
is possible that this initiates the increase in complex formation. It is also possible that
the altered protein in the nuclei of obese rats is not a DNA binding protein. This altered
protein may stabilize the complex by protein-protein interaction.

Since HNF3 is

probably one of the three proteins, the expression of HNF3 gene might be different
between lean and obese rats. However, northern blot analysis showed no significant
difference in HNF3 mRNA levels between lean and obese rats. Therefore the increased
number of DNA-protein complex formation may result from an increased affinity of
HNF3 or increased level or affinity o f the other two proteins in obese rats. However the
possibility that a slightly higher level of HNF3 gene expression results in production of
more HNF3 proteins which are responsible for the larger amount of DNA-protein
complex formation in obese rats could not be entirely excluded at this time.
Increased binding affinity of proteins to DNA could be for different reasons.
One amino acid substitution which results firom a point mutation o f a single codon o f a
gene could be a reason.

Alternatively, post-translational modification, such as

phosphorylation, could change the binding affinity of a protein to the DNA. The role o f
phosphorylation of nuclear proteins in DNA-protein complex formation was investigated
in this study. Dephosphorylation of nuclear proteins increased the formation of specific
DNA-protein complex I but reduced the formation of specific DNA-protein complex II
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in both lean and obese nuclei, suggesting that phosphorylation regulated DNA-protein
complex formation. Alteration of the get retardation pattern has also been demonstrated
using dephosphorylated nuclear proteins from lean and obese rats and DNA fragments
from the upstream region o f the malic enzyme gene (unpublished data). These pieces of
experimental evidence suggested that the nuclear proteins which were involved in the
formation o f DNA-protein complexes must be regulated by phosphorylation.
DNA-protein complex I and complex II formed in gel retardation assay with
60 bp DNA fragment are two specific DNA-protein complexes which have been
demonstrated by adding competitive DNA fragments in gel retardation reactions.
Dephosphorylation of nuclear proteins has opposing effects on these two complexes,
suggesting that there must be some interdependence between these two. It is possible
that the DNA-protein complex II is the precursor o f DNA-protein complex I. If this is
the case, there are a number of possible interpretations of the data. One possibility is
illustrated by model I in Fig. 26. It is possible that all three proteins are DNA binding
proteins. Protein A and B are unaltered. They bind to the DNA and form the same
amount of DNA-protein complex II in both lean and obese rats. The level or affinity of
protein C increases in the nuclei of obese rats. Binding of this protein to DNA results in
an increased formation of complex I in the nuclei of obese rats. Moreover, protein C is
possibly a phosphoprotein. Dephosphorylation of this protein may increase its DNA
binding affinity, therefore the formation o f complex I increases. As a result, the amount
o f complex II is reduced.

Another possibility is illustrated by model II in

Model I of DNA-Protein Interaction.
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Fig. 27. Protein A and B are DNA binding proteins and the level or affinity of these
proteins is the same in the nuclei o f both lean and obese rats, whereas protein C is
involved in complex formation possibly by protein-protein interaction. If the level or
affinity of this protein increases in the nuclei of obese rats, the formation of complex I
increases. Again, this protein is possibly regulated by phosphorylation.
The interdependence of DNA-protein complex I and complex II is supported by
two other pieces o f experimental evidence.

First, proteins isolated by DNA affinity

Dynabeads without extensive wash during purification were capable of reforming the
specific protein-DNA complexes and gave the same pattern in the gel retardation assay.
However, the isolated proteins with extensive washing during purification, could only
form complex U, suggesting that the DNA-protein complex II might be the precursor of
DNA-protein complex 1 and the formation of complex 1 may result from the association
o f complex II with an additional protein factor. This protein may be involved in the
formation of DNA-protein complex by protein-protein interaction and it may be
dissociated from the DNA-protein complex due to the extensive washing during protein
purification. Second, incubation of anti-HNF3a antibody with nuclear proteins in gel
retardation assay not only caused a super-shift of DNA-protein complexes but also
increased the amount of complex II and reduced the amount of complex I. It is possible
that the increased amount of complex II results from a partial disruption o f complex I. If
this is the case, at least one more protein besides HNF3a in the DNA protein complex is
a DNA binding protein.

Fig. 27.

Model II of DNA-Protein Interaction.
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Although the glucocorticoid receptor is not a component of the DNA-protein
complex, the formation o f the specific DNA-protein complexes changes in response to
the change of glucocorticoid status. It has been demonstrated that the formation of the
specific DNA-protein complexes was reduced in gel retardation assay using nuclear
proteins from both adrenalectomized lean and obese rats, whereas the formation of the
DNA-protein complexes was restored using the nuclear proteins from those lean and
obese rats which were ad renalectomized but treated with dexamethasone replacement
thereafter.

This observation indicates that the concentration or affinity o f the

transcription factors which are responsible for the specific DNA-protein complex
formation may be modulated directly or indirectly by glucocorticoids. It is possible that
glucocorticoids directly regulate transcription of the genes coding these transcription
factors. Adrenalectomy may abolish the transcription of these genes, therefore reducing
the levels o f these proteins. Alternatively, the change in levels of glucocorticoids may
result in a change in status of another signal transduction pathway which may indirectly
modulate glucocorticoid induced gene expression. The evidence that phosphorylation o f
nuclear proteins has an effect on DNA-protein complex formation has been
demonstrated in this study, therefore it is more likely that a change in glucocorticoid
status may alter the status of a different signal transduction pathway which may be
involved

in

post-translational

modification,

such

as

phosphorylation.

The

post-translational modification o f nuclear protein may alter the DNA binding affinity o f
these proteins, and thus changes the amount o f DNA-protein complex formation.
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There was a new DNA-protein complex formed when the nuclear extract from
ad renal ectomized rats or the nuclear proteins treated with alkaline phosphatase was used
in the gel retardation assays. In contrast to the specific DNA-protein complex I, this
small DNA-protein complex showed the larger quantity using nuclear extract from lean
rats in comparison with that from obese rats.

The formation o f this DNA-protein

complex reflects the differential response to the status of glucocorticoids and the status
o f phosphorylation of nuclear proteins between lean and obese rats.
It is apparent that the formation of DNA-protein complex changes in response to
the changes of status of glucocorticoids and the status of phosphorylation o f nuclear
proteins. The formation of DNA-protein complex I which showed a larger amount with
nuclear proteins tram obese rats than that from lean rats increased when the
dephosphorylated nuclear proteins were used in the gel retardation assay. The amount of
this

DNA-protein

complex

was

reduced

when

the

nuclear

proteins

from

adrenalectomized rats were used in gel retardation assay and restored when the nuclear
proteins from adrenalectomized rats treated with dexamethasone replacement were used.
Based on this experimental evidence, a hypothetical model of fit mutation and its relation
to the glucocorticoid regulated gene expression has been proposed in Fig. 28. Assuming
that the /a gene encodes a phosphatase inhibitor or protein kinase activator, the mutation
o f the fa gene in obese rats results in an increased activity of phosphatase or reduced
activity

of protein

kinase.

Consequently,

more

transcription

factors

in

a

dephosphorylated form are present in the nuclei of obese rats. The dephosphorylated
transcription factors have a higher affinity to the upstream region o f TAT gene, resulting
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fa gene
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Fig. 28.
Hypothetical Model offa Mutation and its Relation to the Glucocorticoid Regulated Gene Expression.
TF: transcription factor. GR: glucocorticoid receptor. H: glucocorticoid hormone. PK: protein kinase. Hsp90: heat
shock protein 90. p50: protein with molecular weight of 50 KDa. I: inhibitor. A: activator.
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in an increased amount of DNA-protein complex formation. This increased amount of
DNA-protein complex may be responsible for the increased level o f glucocorticoid
induced gene expression in obese rats. On the other hand, the glucocorticoids either
positively regulate phosphatase gene expression or negatively regulate protein kinase
gene expression.

Adrenalectomy abolished the activation o f phosphatase gene

expression or released the inhibition of protein kinase gene expression

by

glucocorticoids, resulting in a reduction of phosphatase activity or an increase o f protein
kinase activity. More transcription factors were present in a phosphorylated form which
had less affinity to the DNA. Therefore, the binding of the transcription factors to the
upstream region of TAT gene was reduced and the expression of the TAT gene was thus
decreased.

Treatment of adrenalectomized rats with replacement of glucocorticoids

reversed the situation and restored the binding activity of transcription factor to the
upstream region o f the TAT gene.

CONCLUDING REMARKS
Summary and Conclusion
Glucocorticoids are essential for the development of experimental obesity but the
molecular mechanism of this dependence is not yet understood. The data in this study
showed a difference in the amount o f nuclear protein binding to the upstream region o f a
glucocorticoid regulated TAT gene between lean and obese rats, suggesting that an
alteration in levels or activity o f a transcription factor or factors was present in the nuclei
o f obese rats.
Gel retardation assays using the 60 bp DNA fragment of the upstream region
(from -2463 to -2402) of TAT gene and the nuclear extracts from lean and obese rats
demonstrated that there were two specific DNA-protein complexes formed (complex I
and complex II). Only complex I was present in larger amounts when nuclear proteins
from obese rats were compared to that from lean rats.
Three proteins from DNA-protein complex I were purified and found to have
approximate molecular weights o f 55, 59 and 62 KDa. The evidence that anti-HNF3a
antibody caused a super-shift o f DNA-protein complex I in gel retardation assay
suggested that HNF3a was one of these three proteins.
There was no significant difference in the amount of HNF3 mRNA between lean
and obese rats detected by northern blot analysis.

Therefore, whether the increased

formation o f DNA-protein complex 1 in obese rats results from an increased level or
affinity of HNF3a could not be determined at this time.
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The correlativity of two specific DNA-protein complexes was observed.
Complex I may result from an association of complex II with an additional protein
factor.

This is supported by the evidence o f the differential reconstitution of

DNA-protein complexes I and II using purified nuclear proteins with different
purification procedure, as well as the evidence o f the altered gel retardation pattern by
dephosphorylation of nuclear protein and by antibody against HNF3a protein.
Although glucocorticoid receptor was not a part of the specific DNA-protein
complex, the formation of the specific DNA-protein complexes changes in response to
the change of glucocorticoid status. This observation indicates that the concentration or
affinity o f the transcription factors that are responsive for the specific DNA-protein
complex formation may be modulated directly or indirectly by glucocorticoids.
Prospects
Based on the results in this study, further research could be done for continuation
of this project.
1.

There was no significant difference in the level of HNF3 mRNA between lean

and obese rats although there was a trend toward more in the obese animal. Whether the
level o f HNF3 mRNA has statistical significance between the population of lean and
obese rats needs to be reevaluated by increasing the number o f animals in northern blot
analysis.
2.

If the HNF3 mRNA level indeed increases in obese rat, a promoter region of

HNF3 gene needs to be cloned to analyze the transcription regulation of this gene and its
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response to the status of glucocorticoids. Alternatively, if no difference o f the HNF3
mRNA levels in lean and obese population can be found, it is possible that an alteration
of DNA binding affinity of HNF3 protein is present in obese rats. Thus the cDNA of
HNF3 gene needs to be cloned in a protein expression vector which is usable for testing
whether the alteration of DNA binding affinity o f HNF3 results from an point mutation
o f the gene or from a post-translational modification, such as phosphorylation.
3.

If neither difference in the level of HNF3 mRNA or the affinity o f HNF3 can be

found, the other two proteins need to be purified using affinity chromatography. 'Hie
N-terminal of the proteins can be sequenced and the resulting amino acid sequence
information is usable for making probes for genes coding these two proteins. The
promoter region of the gene, the gene sequence and the gene product could be analyzed
in a similar way as it is for HNF3.
4.

To construct a plasmid containing the promotor region of TAT gene and the

coding region of a reporter gene. Cotransfection o f this plasmid with the recombinant
plasmids coding for the transcription factors will allow us to study the regulation of TAT
gene by glucocorticoid hormone.
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